VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Mar 01, 2025 To Mar 27, 2025:


Bacillus anthracis (Anthrax)

  1. Pan H, Yu Y, Li X, Wang M, Wen C, Dai Q, Huang L. Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants BMC public health 25(1):933 2025 [PMID: 40065303]
  2. Kimeli P, Mwacalimba K, Tiernan R, Mijten E, Miroshnychenko T, Poulsen Nautrup B. Important Diseases of Small Ruminants in Sub-Saharan Africa: A Review with a Focus on Current Strategies for Treatment and Control in Smallholder Systems Animals : an open access journal from MDPI 15(5) 2025 [PMID: 40075989]

Brucella (Brucellosis)

  1. Olsen SC, Putz E, Boggiatto PM. Mucosal and systemic humoral responses after experimental Brucella abortus challenge in non-vaccinated or RB51-vaccinated elk Research in veterinary science 187:105591 2025 [PMID: 40106936]
  2. Gharekhani J, Hemati Z, Adabi M, Asadi FT, Dadar M. Role of RB51 vaccine in cow milk contamination of traditional milk sales centers Tropical animal health and production 57(2):114 2025 [PMID: 40072655]
  3. Yektay S, Alimi R, Attarian F, Alizadeh Siuki H, Aval MG, Gholizadeh A. Brucellosis and associated risk factors, spatial distribution and cluster analysis: Case study in Khorasan Razavi Province, Iran Journal of infection and public health 18(6):102747 2025 [PMID: 40090171]
  4. Serpa Gonçalves M, Oliveira MM, Silva EMM, Souza LB, Andrade RS, Custódio DADC, Ferreira ACR, Costa ACTRB, Freire HR, Pereira CR, Oliveira IRC, Bueno Filho JSS, Lage AP, Dorneles EMS. Short communication: Effects of age on the immune response induced by Brucella abortus S19 or RB51 vaccination in calves Veterinary immunology and immunopathology 283:110919 2025 [PMID: 40101522]
  5. Wei Z, Zhang S, Wang X, Xue Y, Dang S, Zhai J. Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects Frontiers in immunology 16:1524317 2025 [PMID: 40103818]

Clostridium perfringens

  1. Tan WX, Ye T, Zhang QM, Zhang M, Chen XT, Tang LY, Yang MT, Jiang J, Zhao Q. Prevalence of Clostridium perfringens in sheep (Ovis aries) and goat (Capra hircus) populations across Asia: A systematic review and meta-analysis Research in veterinary science 187:105605 2025 [PMID: 40054367]
  2. Shamshirgaran MA, Golchin M. Oral and parenteral vaccination of broiler chickens with Recombinant NetB antigen from Clostridium perfringens confers significant protection against necrotic enteritis BMC veterinary research 21(1):167 2025 [PMID: 40087742]

Coronavirus

  1. Zhang C, Zhang YQ, Liu RB, Ma YT, Zhao LK, Yin FQ, Tu J, Yao YY. Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies Annals of medicine 57(1):2478319 2025 [PMID: 40135763]
  2. Sharma K, Syeda S, Shah SM, Kori SA, Shetty P, Kazi S, Khaiterpal A, Choudhary A, Pathak S, Ahmed S. Overcoming barriers to medical countermeasures: Strengthening global biosecurity Human vaccines & immunotherapeutics 21(1):2483043 2025 [PMID: 40132079]
  3. Doherty TM, Weinberger B, Didierlaurent A, Lambert PH. Age-related changes in the immune system and challenges for the development of age-specific vaccines Annals of medicine 57(1):2477300 2025 [PMID: 40110678]
  4. Liu G, Gonzales MLAM, Chan WH, Memon IA, Alam A, Lee H, Wickramasinghe H, Pham QT, Dayal R, Levin M, Huang YC, Buttery J, Ong-Lim ALT, Kwan MYW. Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region Human vaccines & immunotherapeutics 21(1):2477965 2025 [PMID: 40104999]
  5. Rudolph AE, Al Akoury N, Bogdanenko N, Markus K, Whittle I, Wright O, Haridy H, Spinardi JR, McLaughlin JM, Kyaw MH. Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review Human vaccines & immunotherapeutics 21(1):2474772 2025 [PMID: 40079963]
  6. Zhang X, Fu Y, Chen S, Liu G, Wang Y, He Q, Wang Q, Li N, Wang Z, Chen L, Wang J, Liang Z, Xu M, Mao Q. Exploring the standardization of human nasal antibody measurements Emerging microbes & infections 14(1):2475822 2025 [PMID: 40071971]
  7. Alshagrawi S, Hazazi A. Impact of COVID-19 pandemic on influenza vaccination rates among healthcare workers and the general population in Saudi Arabia: A meta-analysis Human vaccines & immunotherapeutics 21(1):2477954 2025 [PMID: 40068961]
  8. Gauna F, Raude J, Khouri C, Cracowski JL, Ward JK. Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review Human vaccines & immunotherapeutics 21(1):2471225 2025 [PMID: 40058398]
  9. Hwang YH, Min DH, Beom Park W. Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection Human vaccines & immunotherapeutics 21(1):2473795 2025 [PMID: 40051347]
  10. Zhang J, Zeng F, Li Y, Mu C, Liu C, Wang L, Peng X, He L, Su Y, Li H, Wang A, Feng L, Gao D, Zhang Z, Xu G, Wang Y, Yue R, Si J, Zheng L, Zhang X, He F, Yi H, Tang Z, Li G, Ma K, Li Q. The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants Human vaccines & immunotherapeutics 21(1):2473183 2025 [PMID: 40045463]
  11. Hong L, Li J, Zeng W, Li Y, Yu C, Zhao S, Chen L, Feng Y. The seroprevalence of adenoviruses since 2000(1) Emerging microbes & infections 14(1):2475831 2025 [PMID: 40035700]
  12. Warang P, Singh G, Moshir M, Binazon O, Laghlali G, Chang LA, Wouters H, Vanhoenacker P, Notebaert M, Elhemdaoui N, Augustynková K, Steeland S, Ulrichts P, Baumeister J, Schotsaert M. Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models Human vaccines & immunotherapeutics 21(1):2470542 2025 [PMID: 40028815]
  13. Singh S, Liu Y, Burke M, Rayaprolu V, Stein SE, Hasan SS. Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct Journal of structural biology: X 11:100123 2025 [PMID: 40046771]
  14. Haddox S, Wu P, Singh S, Qin F, Engel J, Kian A, Ahmad S, Li H, Wu P. Landscape of chimeric RNAs in COVID-19 patient blood Genes & diseases 12(3):101348 2025 [PMID: 40110491]
  15. Yuan J, Dong M, Ip DKM, So HC, Liao Q. Dual decision-making routes for COVID-19 and influenza vaccines uptake in parents: A mixed-methods study British journal of health psychology 30(2):e12789 2025 [PMID: 40052507]
  16. Larsen TG, Ginty JR, Jessen R, Nielsen RB, Jensen A, Botnen AB, Wilkowski B, Rasmussen C, Brødbæk DL, Shaw DS, Benameur E, Rasmussen M, Trebbien R, Mortensen S, Olsen SS, Chong S, Krause TG, Schneider UV, Vangsted AM, Steenhard NR, Møller FT. Virus Monitoring in Denmark: A Community-Based Self-Sampling System to Surveil Respiratory Viruses and Associated Symptoms Journal of medical virology 97(4):e70293 2025 [PMID: 40130741]
  17. Hall TM, Attwell K, Morgan VA, Hincks S, Waterreus A. Exploring barriers to the COVID-19 vaccine in people with psychoses in Western Australia Preventive medicine reports 52:103025 2025 [PMID: 40124135]
  18. Zabalza A, Thompson A, Rotstein DL, Bar-Or A, Montalban X. Multiple sclerosis and COVID-19: interactions and unresolved issues The Lancet. Neurology 24(4):361-370 2025 [PMID: 40120619]
  19. Gambari R, Papi C, Gasparello J, Agostinelli E, Finotti A. Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene Experimental and therapeutic medicine 29(4):85 2025 [PMID: 40084194]
  20. Fierlbeck K, Gautier L, Usher S, Allin S, Sriram V, Berman P. Testing "the science": A comparative analysis of COVID-19 testing policy across four Canadian provinces Social science & medicine (1982) 371:117880 2025 [PMID: 40081167]
  21. Brown KM, Courtot B, Porter Z, Hinojosa S. Better Together: Implementation of a Public Health Learning Community During the COVID-19 Pandemic American journal of public health 115(4):469-472 2025 [PMID: 40073360]
  22. White BK, Burns SK, Carson J, Scott JA. 'I'm glad my baby has weaned so I don't need to make that decision.' Understanding breastfeeding-related COVID-19 vaccine narratives on social media Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals 36(2):e946 2025 [PMID: 40069117]
  23. Rodriguez-Idiazabal L, Quintana JM, Garcia-Asensio J, Legarreta MJ, Larrea N, Barrio I. Clinically meaningful phenotypes among SARS-CoV-2 reinfections: Informing prevention strategies for future pandemics Preventive medicine 193:108259 2025 [PMID: 40064450]
  24. Jones MU, Richard SA, Malloy AMW, Colombo RE, May J, Saunders D, Lindholm DA, Ganesan A, Sablak C, Hickey PW, Dobson CP, Pollett SD, Flanagan R. Clinical Characteristics and Outcomes of Cardiac Findings in Young Persons Following SARS-CoV-2 Infection The Pediatric infectious disease journal 44(4):342-345 2025 [PMID: 40063968]
  25. Dhawan M, Thakur N, Sharma M, Rabaan AA. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 185:117936 2025 [PMID: 40056829]
  26. Xu H, Yang M, Liu S, Zheng F, Li Y, Li Y, Wang C, Qian J, Zhao Y, Yang S, Sun M, Song X, Guo R, Zhou J, Fan B, Li B. Constructions and immunogenicity evaluations of two porcine epdemic diarrhea virus-like particle vaccines Veterinary microbiology 303:110451 2025 [PMID: 40048881]
  27. Kocharovskaya MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, Grafskaia EN, Lyukmanova EN, Kirpichnikov MP, Shenkarev ZO. Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987 Biochemical and biophysical research communications 755:151558 2025 [PMID: 40043614]
  28. Benlarbi M, Kenfack DD, Dionne K, Côté-Chenette M, Beaudoin-Bussières G, Bélanger É, Ding S, Goni OH, Ngoume YF, Tauzin A, Medjahed H, Ghedin E, Duerr R, Finzi A, Tongo M. Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon Virology 605:110467 2025 [PMID: 40037139]
  29. Li P, Faraone JN, Hsu CC, Chamblee M, Liu Y, Zheng Y-M, Xu Y, Carlin C, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Bednash JS, Xu K, Liu S-L. Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants mBio :e0046425 2025 [PMID: 40136024]
  30. Jana ID, Kanjo K, Roy S, Bhasin M, Bhattacharya S, Banerjee I, Jana S, Chatterjee A, Chakrabarti AK, Chakraborty S, Mukherjee B, Varadarajan R, Mondal A. Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants Journal of virology :e0005125 2025 [PMID: 40135898]
  31. Li P, Faraone JN, Hsu CC, Chamblee M, Liu Y, Zheng Y-M, Xu Y, Carlin C, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Bednash JS, Xu K, Liu S-L. Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability Journal of virology :e0024225 2025 [PMID: 40135879]
  32. Akram S, Aftab R, Baloch QB, Ullah F, Alonazi WB, Baloch VQ, Amin H, Alam MS. The conditionality of COVID-19 vaccine acceptance: A qualitative study in Pakistan African journal of reproductive health 29(3):143-159 2025 [PMID: 40135475]
  33. Ladeira F, Nobrega C, Cerqueira J. Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study Journal of neurology 272(4):288 2025 [PMID: 40131515]
  34. Dadonaite B, Burrell AR, Logue J, Chu HY, Payne DC, Haslam DB, Staat MA, Bloom JD. SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals Journal of virology :e0010925 2025 [PMID: 40130874]
  35. Chen X, Shi T, Chen F, Xie X, Fang H, Wu Z, Liu Y, Huang Y, Wang Q, Nie G, Xu J, Shao D. Orally Antigen-Engineered Yeast Vaccine Elicits Robust Intestinal Mucosal Immunity ACS nano 19(11):10841-10853 2025 [PMID: 40082064]
  36. Moré JS, Serbena DR, Camargo LGG, Clemente PA, Santos FSD, Bonini JS. How the COVID-19 pandemic affected routine child vaccination: an integrative review Einstein (Sao Paulo, Brazil) 23:eRW1119 2025 [PMID: 40136151]
  37. Zheng H, Qiu C, Tian H, Zhu X, Yin B, Zhou Z, Li X, Zhao J. Host restriction factors against porcine epidemic diarrhea virus: a mini-review Veterinary research 56(1):67 2025 [PMID: 40128890]
  38. Exley J, Stubbs E, Wittenberg R, Mays N. An international comparison of longitudinal health data collected on long COVID in nine high income countries: a qualitative data analysis Health research policy and systems 23(1):37 2025 [PMID: 40128775]
  39. Song L, Cui Y, Wang Q, Tan R, Wen Y, Meng C, Jiao X, Pan Z. Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine Viral immunology 2025 [PMID: 40127244]
  40. Ye QY, Jiang ZT, Jiang Y, Cai JW, Zhou Z, Song J, Wang Q, Wu QQ, Zhao G, Chen J, Ling QH. Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant Archives of virology 170(5):88 2025 [PMID: 40126697]
  41. Li H, Hu Y, Li J, He J, Yu G, Wang J, Lin X. Intranasal prime-boost RNA vaccination elicits potent T cell response for lung cancer therapy Signal transduction and targeted therapy 10(1):101 2025 [PMID: 40122855]
  42. Vachon A, Keeshan A, Galipeau Y, Crawley AM, Langlois MA, Cooper CL. Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis Vaccine 55:127034 2025 [PMID: 40121732]
  43. Patel M, Gokun Y, DeGraffinreid C, Washington C, Baltic RD, Ringel MD, Paskett ED. COVID-19 vaccination uptake in Ohio: analyzing the difference between metro and non-metro residents BMC public health 25(1):1103 2025 [PMID: 40121451]
  44. Anraku Y, Kita S, Onodera T, Sato A, Tadokoro T, Ito S, Adachi Y, Kotaki R, Suzuki T, Sasaki J, Shiwa-Sudo N, Iwata-Yoshikawa N, Nagata N, Kobayashi S, Kazuki Y, Oshimura M, Nomura T, Sasaki M, Orba Y, Suzuki T, Sawa H, Hashiguchi T, Fukuhara H, Takahashi Y, Maenaka K. Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants Communications biology 8(1):483 2025 [PMID: 40121330]
  45. Weinberg GA, de St Maurice AM, Qwaider YZ, Stopczynski T, Amarin JZ, Stewart LS, Williams JV, Michaels MG, Sahni LC, Boom JA, Spieker AJ, Klein EJ, Englund JA, Staat MA, Schlaudecker EP, Selvarangan R, Schuster JE, Harrison CJ, Derado G, Toepfer AP, Moline HL, Halasa NB, Szilagyi PG. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in U.S. Children Journal of the Pediatric Infectious Diseases Society 2025 [PMID: 40120104]
  46. Sábato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega MG, Sebudde N, Mylonakis E, Braun DL, Hatlen T, Kimuli I, Kitko C, Mugerwa H, Kitonsa J, Kim K, Tien PC, Highbarger J, McCormack AL, Sanchez A, Murray DD, Babiker AG, Davey VJ, Files DC, Gelijns AC, Higgs ES, Kan VL, Matthews GV, Pett SL, Lane HC, Reilly C, Goodman AL, Lundgren JD, Moltó J. SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial) Scientific reports 15(1):9882 2025 [PMID: 40118946]
  47. Jung S, Cho Y, Kwon J, Yang Y, Lee J, Kim S. Assessing student satisfaction with university policies related to in-person classes in the era of COVID-19: a case study from Korea Scientific reports 15(1):9876 2025 [PMID: 40118927]
  48. Singh B, Lipunga GD, Thangavelu P, Dhar S, Ferreira Cronemberger L, Abhilash KPP, Abraham AM, de Brito CAA, Brito Ferreira ML, Chandrashekar N, Duarte R, Fajardo Modol A, Ghale BC, Kang G, Gowda VK, Kuriakose K, Lant S, Mallewa M, Mbale E, Moore SC, Mwangalika G, Kamath PBT, Navvuga P, Nyondo-Mipando AL, Phiri TJ, Pimentel Lopes de Melo C, Pradeep BS, Rawlinson R, Sheha I, Thomas PT, Newton CR, de Sequeira PC, Sejvar JJ, Dua T, Turtle L, Verghese VP, Arraes LWMS, Desmond N, Easton A, Jones JA, Lilford RJ, Netravathi M, McGill F, Michael BD, Mwapasa V, Griffiths MJ, Parry CM, Ravi V, Burnside G, Cornick J, França RFO, Desai AS, Rupali P, Solomon T. A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study Lancet (London, England) 405(10483):991-991003 2025 [PMID: 40081400]
  49. Fernandes-Siqueira LO, Melo RRA, Wermelinger LS, Almeida FCL, Salmon D, Ferreira GC, DA Poian AT. An institutional COVID-19 initiative: creation of a biobank and serological data analysis in pre- and post-vaccination cohorts Anais da Academia Brasileira de Ciencias 97(1):e20240819 2025 [PMID: 40136202]
  50. Jia X, Liu H, Sun Y, Wang N, Qian M, Wang Z, Li M, Xiang Y, Wei Z, Zheng L. Effective preparation and immunogenicity analysis of antigenic proteins for prevention of porcine enteropathogenic coronaviruses PEDV/TGEV/PDCoV International journal of biological macromolecules :142394 2025 [PMID: 40122422]
  51. Dariotis JK, Eldreth DA, Sloane SM, Noor I, Smith RL. Distrust, trauma, doubt, and protective reactions to coronavirus disease 2019: cautionary tales and lessons to learn for future pandemics: a case report Journal of medical case reports 19(1):131 2025 [PMID: 40119468]
  52. Detrille A, Huvelle S, van Gils MJ, Geara T, Pascal Q, Snitselaar J, Bossevot L, Cavarelli M, Dereuddre-Bosquet N, Relouzat F, Contreras V, Chapon C, Caillé F, Sanders RW, Le Grand R, Naninck T. Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates Nature communications 16(1):2816 2025 [PMID: 40118860]
  53. Pinpathomrat N, Seeyankem B, Sophonmanee R, Ongarj J, Surasombatpattana S. Impact of pre-existing immunity on humoral and cellular responses to CoronaVac in SARS-CoV-2 variants: A focus on common human Coronaviruses Asian Pacific journal of allergy and immunology 2025 [PMID: 40117238]
  54. Grimes DR, Gorski DH. Quantifying Public Engagement With Science and Malinformation on COVID-19 Vaccines: Cross-Sectional Study Journal of medical Internet research 27:e64679 2025 [PMID: 40116851]
  55. Zhou M, Ma J, Fang M, Liu X, Zhang C, Wu K, Ye J, Zhang Y, Yuan Q, Chen R, Chen P, Zhu H, Guan Y, Cheng T, Yuan L, Xia N. Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimated perniciousness of severe acute respiratory syndrome coronavirus 2 EG.1 variant iScience 28(3):111875 2025 [PMID: 40034851]
  56. Luo S, Yin L, Liu X, Wang X. Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases Biosensors 15(3) 2025 [PMID: 40136995]
  57. Hamid S, Simeone RM, Newhams MM, Halasa N, Fleming-Dutra KE, Orzel-Lockwood AO, Wu MJ, Randolph AG, Campbell AP, Zambrano LD. Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023 Vaccine 54:126891 2025 [PMID: 40117941]
  58. Kelleni MT. What would Hippocrates have sworn upon witnessing the COVID-19 mandates and mortality paradox World journal of experimental medicine 15(1):98575 2025 [PMID: 40115753]
  59. Garneau WM, Wang K, Liang T, Xu Y, Gladstone DE, Avery RK, D'Alessio FR, Robinson ML, Sahetya SK, Garibaldi BT, Gebo KA, Dioverti MV. Effect of antecedent B-cell depletion therapy for patients hospitalized with COVID-19 within a single health system: a propensity score analysis Scientific reports 15(1):9647 2025 [PMID: 40113850]
  60. Baakliny M, Ghosn N, Saleh N, Maison P. Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022 PloS one 20(3):e0318344 2025 [PMID: 40112019]
  61. Hidaka Y, Jo N, Kikuchi O, Fukahori M, Sawada T, Shimazu Y, Yamamoto M, Kometani K, Nagao M, Nakajima TE, Muto M, Morita S, Hamazaki Y. Effect of pre-vaccination blood and T-cell phenotypes on antibody responses to COVID-19 mRNA vaccine International immunology 2025 [PMID: 40110889]
  62. Deepthi V, Sasikumar A, Mohanakumar KP, Rajamma U. Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silico Scientific reports 15(1):9562 2025 [PMID: 40108271]
  63. Vaughan K, Mokena OT, Rankgoane-Pono G, Keetile M, Griffiths UK. Costs of delivering COVID-19 vaccine in Botswana during the height of the pandemic: a retrospective study BMC health services research 25(1):405 2025 [PMID: 40108612]
  64. Cassocera M, Bauhofer AFL, Chissaque A, Munlela B, Guimarães E, Isaías T, Conjo C, Maculuve B, Chicumbe S, de Deus N. Regional difference on rotavirus vaccine coverage in children with diarrhea in Mozambique, before and during COVID-19 pandemic: a cross-sectional analysis BMC infectious diseases 25(1):382 2025 [PMID: 40108531]
  65. Zidan AA, Jad AY, Zakaria NH, El-Hariri HM, El-Setouhy M. Assessment of the factors affecting the clinical outcomes of infection and safety of vaccines against SARS-CoV-2 among Egyptian patients BMC infectious diseases 25(1):384 2025 [PMID: 40108502]
  66. Zadeh VR, Lew JM, Zahoor MA, Santer D, Feld JJ, Falzarano D. Combination Therapy Enhances the Antiviral Activity of IFN-λ Against SARS-CoV-2 and MERS-CoV Virus research :199560 2025 [PMID: 40113092]
  67. Munjita SM. Understanding vaccine hesitancy: Insights from social media on polio, human papilloma virus, and COVID-19 in Zambia Digital health 11:20552076251326131 2025 [PMID: 40109405]
  68. Pasquier JC, Plourde M, Ramanathan S, Chaillet N, Boivin G, Laforest-Lapointe I, Allard-Chamard H, Baron G, Beaulieu JF, Fülöp T, Généreux M, Mâsse B, Robitaille J, Valiquette L, Bilodeau S, H Buch D, Piche A. P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol BMJ open 15(3):e088231 2025 [PMID: 40107677]
  69. Chaudhry T, Tum P, Tam HZ, Brentnall A, Smethurst H, Kielmann K, Kunst H, Hargreaves S, Campbell CNJ, Griffiths C, Zenner D. COVER-ME: developing and evaluating community-based interventions to promote vaccine uptake for COVID-19 and influenza in East London minority ethnicity (ME) and underserved individuals - protocol for a pilot randomised controlled trial BMJ open 15(3):e092568 2025 [PMID: 40107676]
  70. Fernandes RS, de Assis Burle-Caldas G, Sergio SAR, Bráz AF, da Silva Leite NP, Pereira M, de Oliveira Silva J, Hojo-Souza NS, de Oliveira B, Fernandes APSM, da Fonseca FG, Gazzinelli RT, Dos Santos Ferreira D, Teixeira SMR. The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens Journal of nanobiotechnology 23(1):221 2025 [PMID: 40102899]
  71. Mellors J, Dhaliwal R, Longet S, Tipton T, Barnes E, Dunachie SJ, Klenerman P, Hiscox J, Carroll M. Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals Nature communications 16(1):2666 2025 [PMID: 40102474]
  72. Jurczak M, Kaczmarek J, Kowalewska-Pietrzak M, Druszczynska M. Immunomodulatory Effect of the Bacillus Calmette-Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens Archivum immunologiae et therapiae experimentalis 73(1) 2025 [PMID: 40101137]
  73. Rumik A, Paradowska-Stankiewicz I. Pertussis in Poland in 2022 Przeglad epidemiologiczny 78(4):428-438 2025 [PMID: 40101009]
  74. Taylor-Abdulai HB, Dzantor EK, Mensah NK, Asumah MN, Ocansey S, Arhin SK, Barnes P, Opoku VO, Mankir ZJ, Famieh SA, Botchey CPK. Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study PloS one 20(3):e0319798 2025 [PMID: 40100903]
  75. Loubet P, Benotmane I, Fourati S, Malard F, Vuotto F, Blanchard E, Raffi F, Nguyen S, de Prost N, Avouac J. Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective Infectious diseases and therapy 2025 [PMID: 40100618]
  76. Zhang H, Ouyang S, Qu Y, Li Z, Jiang Y, Peng T, Yang G, Chen T, Li B, Shen C, Zhao W. Humoral immune response characteristics of vulnerable populations against SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB Archives of virology 170(4):82 2025 [PMID: 40100292]
  77. Ramalingam R, Gnanaprakasam AJ, Boulaaras S. Stability and control analysis of COVID-19 spread in India using SEIR model Scientific reports 15(1):9095 2025 [PMID: 40097545]
  78. Mahmoud I, Ahmed AE, Shaker O. Role of furin in the severity of COVID-19 infection via effects on miR-20b and miR-106a Molecular biology reports 52(1):320 2025 [PMID: 40095093]
  79. Weiss S, Lin HM, Acosta E, Komarova NL, Chen P, Wodarz D, Baine I, Duerr R, Wajnberg A, Gervais A, Bastard P, Casanova JL, Arinsburg SA, Swartz TH, Aberg JA, Bouvier NM, Liu ST, Alvarez RA, Chen BK. Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles The Journal of clinical investigation 135(6) 2025 [PMID: 40091845]
  80. Safiriyu AA, Hussain A, Dewangan N, Kasle G, Shindler K, Pal D, Das Sarma J. The fusion peptide of the spike protein S2 domain may be a mimetic analog of β-coronaviruses and serve as a novel virus-host membrane fusion inhibitor Antiviral research 237:106144 2025 [PMID: 40101846]
  81. Huang Z, Gao C, Huang S, Lin S, Zhang W, You J, Chen X, Zhou P, Zhang G, Gong L. The Alpha-coronavirus E protein inhibits the JAK-STAT pathway signaling by triggering STAT2 degradation through OPTN- and NBR1-mediated selective autophagy Autophagy 2025 [PMID: 40091174]
  82. Stephenson KE. Next-Generation Coronavirus Disease 2019 Vaccines: Clinical Data and Future Directions Infectious disease clinics of North America 2025 [PMID: 40090832]
  83. Winters M, Christie S, Melchinger H, Iddrisu I, Al Hassan H, Ewart E, Mosley L, Alhassan R, Shani N, Nyamuame D, Lepage C, Thomson A, Atif AN, Omer SB. Debunking COVID-19 vaccine misinformation with an audio drama in Ghana, a randomized control trial Scientific reports 15(1):8955 2025 [PMID: 40089600]
  84. Heng F, Sun Y, Li L, B Gilbert P. Estimation and Hypothesis Testing of Strain-Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID-19 Vaccine Trial Statistics in medicine 44(6):e10345 2025 [PMID: 40072429]
  85. Luo Z, Kent DE, Shah P, Poplausky D, MacRae MC, Boomsma C, Jasper JM, Wurcel AG, Byhoff E, Tang AM, Doron S, Subbaraman R. Perceptions of sources of transmission among hospital employees infected with severe acute respiratory coronavirus 2 (SARS-CoV-2) in an urban tertiary care hospital: a qualitative study to inform future pandemic management Antimicrobial stewardship & healthcare epidemiology : ASHE 5(1):e78 2025 [PMID: 40109910]
  86. Alrubayyi A, Huang H, Gaiha GD. Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes Infectious disease clinics of North America 2025 [PMID: 40089444]
  87. Shumaker AH, Bhimraj A. Pharmacologic Treatment and Management of Coronavirus Disease 2019 Infectious disease clinics of North America 2025 [PMID: 40089443]
  88. Estadilla CDS, Cicolani C, Blasco-Aguado R, Saldaña F, Borri A, Mar J, Van-Dierdonck JB, Ibarrondo O, Stollenwerk N, Aguiar M. The impact of non-pharmaceutical interventions on COVID-19 transmission and its effect on life expectancy in two European regions BMC public health 25(1):1004 2025 [PMID: 40087626]
  89. Afroze F, Arafat SM, Ahmed CM, Alam B, Banu S, Islam MZ, Mahfuz M, Qadri F, Bhuiyan TR, Parvin I, Ackhter MM, Islam F, Sultana M, Sultana E, Rahaman MFU, Khan AH, Hasan MN, Ahmed S, Chisti MJ, Ahmed T. Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study Journal of global health 15:04075 2025 [PMID: 40084715]
  90. Cox SN, Roychoudhury P, Frivold C, Acker Z, Babu TM, Boisvert CL, Carone M, Ehmen B, Englund JA, Feldstein LR, Gamboa L, Grindstaff S, Grioni HM, Han PD, Hoffman KL, Kim HG, Kuntz JL, Lo NK, Lockwood CM, McCaffrey K, Mularski RA, Hatchie TL, Reich SL, Schmidt MA, Smith N, Starita LM, Varga A, Yetz N, Naleway AL, Weil AA, Chu HY. Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 40084542]
  91. Kogevinas M, Karachaliou M, Espinosa A, Iraola-Guzmán S, Castaño-Vinyals G, Delgado-Ortiz L, Farré X, Blay N, Pearce N, de Basea MB, Nogués EA, Dobaño C, Moncunill G, de Cid R, Garcia-Aymerich J. Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia BMC medicine 23(1):140 2025 [PMID: 40082863]
  92. Myburgh L, Karsjens H, Blanas A, de Ligt A, van Loon K, Huijbers EJM, van Beijnum JR, Engbersen DJM, Rekiki A, Mignon C, Vratskikh O, Griffioen AW. Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine Vaccine 54:126989 2025 [PMID: 40088511]
  93. Kamin-Friedman S, Davidovitch N, Levine H, Nitzan D. IHR amendments and the "pandemic agreement" an Israeli perspective Israel journal of health policy research 14(1):13 2025 [PMID: 40083009]
  94. Shahrebabak AG, Rezaei M, Shahpar A, Nezhad NZ, Sarasyabi MS, Nakhaie M, Shahrebabak MG, Bahri RA. The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review BMC infectious diseases 25(1):358 2025 [PMID: 40082759]
  95. Guo J, Fu Z, Zhang Y, Xu M, He J, Zhang H, Zhang Q, Song J, Lin K, Fan M, He Z, Yuan G, Jiang N, Huang H, Qiu C, Ai J, Zhang W. The High Expression of PD-1 Defines A Subpopulation of Tfh Cells Responding to COVID-19 Vaccine in Humans Genomics, proteomics & bioinformatics 2025 [PMID: 40080696]
  96. Ali SA, Chen YL, Tseng HS, Ayalew H, She JW, Gautam B, Tu HL, Hsiao YS, Yu HH. Poly(3,4-ethylenedioxythiophene) Nanorod Arrays-Based Organic Electrochemical Transistor for SARS-CoV-2 Spike Protein Detection in Artificial Saliva ACS sensors 2025 [PMID: 40080450]
  97. Aligolighasemabadi F, Bakinowska E, Kiełbowski K, Sadeghdoust M, Coombs KM, Mehrbod P, Ghavami S. Autophagy and Respiratory Viruses: Mechanisms, Viral Exploitation, and Therapeutic Insights Cells 14(6) 2025 [PMID: 40136667]
  98. Leong KY, Tham SK, Poh CL. Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications Virology journal 22(1):71 2025 [PMID: 40075519]
  99. Ebrahimi OV, Sandbakken EM, Moss SM, Johnson SU, Hoffart A, Bauermeister S, Solbakken OA, Westlye LT, Leonardsen EH. Modifiable risk factors of vaccine hesitancy: insights from a mixed methods multiple population study combining machine learning and thematic analysis during the COVID-19 pandemic BMC medicine 23(1):155 2025 [PMID: 40075423]
  100. Ariyaratne P, Ramasinghe LP, Ayyash JS, Kelley TM, Plant-Collins TA, Shinkle LW, Zuercher AM, Chen J. Application and significance of SIRVB model in analyzing COVID-19 dynamics Scientific reports 15(1):8526 2025 [PMID: 40075115]
  101. Mutmainah, Murai Y, Fujimoto A, Kawamura R, Kitamura A, Koolath S, Usuki S, Sasaki M, Orba Y, Igarashi Y, Sawa H, Sato A, Monde K. Malabaricone C isolated from edible plants as a potential inhibitor of SARS-CoV-2 infection Scientific reports 15(1):8518 2025 [PMID: 40074774]
  102. Adamu H, Lawal S, Bawa IA, Sani AM, Adamu AA. Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria PloS one 20(3):e0277585 2025 [PMID: 40073304]
  103. Tausk DV, Spira B. Does mask usage correlate with excess mortality? Findings from 24 European countries BMC public health 25(1):913 2025 [PMID: 40069661]
  104. Langat R, Burns N, Daud I, Kibuuka H, Owuoth J, Sing'oei V, Maswai J, Parker Z, Tiamiyu A, Bahemana E, Gervas R, Dear NF, Frndak S, Parikh AP, Duff ER, Imbach M, Omar B, Hern J, Shah N, Ake JA, Crowell TA, Romo ML. The vast majority of SARS-CoV-2 infections were asymptomatic in a clinic-based cohort of people with and without HIV in four African countries BMC infectious diseases 25(1):345 2025 [PMID: 40069614]
  105. Sonehara K, Uwamino Y, Saiki R, Takeshita M, Namba S, Uno S, Nakanishi T, Nishimura T, Naito T, Sato G, Kanai M, Liu A, Uchida S, Kurafuji T, Tanabe A, Arai T, Ohno A, Shibata A, Tanaka S, Wakui M, Kashimura S, Tomi C, Hara A, Yoshikawa S, Gotanda K, Misawa K, Tanaka H, Azekawa S, Wang QS, Edahiro R, Shirai Y, Yamamoto K, Nagao G, Suzuki T, Kiyoshi M, Ishii-Watabe A, Higashiue S, Kobayashi S, Yamaguchi H, Okazaki Y, Matsumoto N, Masumoto A, Koga H, Kanai A, Oda Y, Suzuki Y, Matsuda K, Kitagawa Y, Koike R, Kimura A, Kumanogoh A, Yoshimura A, Imoto S, Miyano S, Kanai T, Fukunaga K, Hasegawa N, Murata M, Matsushita H, Ogawa S, Okada Y, Namkoong H. Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity Cell genomics 5(3):100783 2025 [PMID: 40043710]
  106. Chuang CC, Liu YC, Ou YY. DeepEpiIL13: Deep Learning for Rapid and Accurate Prediction of IL-13-Inducing Epitopes Using Pretrained Language Models and Multiwindow Convolutional Neural Networks ACS omega 10(9):9675-9683 2025 [PMID: 40092768]
  107. Mukenge EK, Sumbu BM, Nkodila AN, Muwonga JM, Makulo JR, Ngole MZ, Bepouka BI, Longokolo MM, Kamwiziku G, Situakibanza HN, Kayembe JN, Longo-Mbenza B, Mvumbi GL, Buassa-Bu-Tsumbu B, Makangara JC, Mashinda DK, Mafuta EM, Mangala DS, Nkanga MN, Ilunga GN, Nkunda FT, Lengo CN, Ahuka SM. Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort study BMC infectious diseases 25(1):342 2025 [PMID: 40069636]
  108. Park YJ, Jankowski W, Hurst NC, Fry JW, Schwabe NF, Tan LCC, Sauna ZE. Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants The AAPS journal 27(2):58 2025 [PMID: 40069439]
  109. Htet H, Wichaidit W, Chuaychai A, Sottiyotin T, Htet KKK, Sriplung H, Chongsuvivatwong V. Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study PloS one 20(3):e0317714 2025 [PMID: 40067860]
  110. Liu H, Liu T, Wang X, Zhu X, He J, Wang H, Fan A, Zhang D. Design and development of a novel multi-epitope DNA vaccine candidate against infectious bronchitis virus: an immunoinformatic approach Archives of microbiology 207(4):84 2025 [PMID: 40067376]
  111. Philipson TJ, Fendrick AM, Kataria A, Di Cera G, Zhao Q, Guo S, Abbasi A. COVID-19 Biopharmaceutical Innovation and Industry Appropriation Forum for health economics & policy 2025 [PMID: 40059812]
  112. Yang B, Yu H, Yao W, Wang H. Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib Frontiers in immunology 16:1476584 2025 [PMID: 40129975]
  113. Lai C, Wang Y, Shi F, Geng N, Liu Z, Pan W, Shi H, Ma Y, Liu B. The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients Journal of inflammation research 18:3511-3522 2025 [PMID: 40093955]
  114. Emery I, Rosen C. Adult Long Coronavirus Disease 2019: Definition, Prevalence Pathophysiology, and Clinical Manifestations Infectious disease clinics of North America 2025 [PMID: 40068974]
  115. Ha NY, Kim AR, Jeong H, Cheon S, Park CR, Choe JH, Kim HJ, Yoon JW, Kim M, An MY, Jung S, Do HN, Lee J, Kim YS. Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count Journal of Korean medical science 40(9):e28 2025 [PMID: 40065712]
  116. Correale P, Baglio G, Parrella R, Saladino RE, Cuomo N, Scarano F, Francone M, Cuzzola M, Foti G, Mutti L, Pentimalli F, Giordano A. A rapid ecologic analysis, confirmed by a case-control study, identifies class I HLA alleles correlated to the risk of COVID-19 Journal of translational medicine 23(1):303 2025 [PMID: 40065352]
  117. Rashid T, Arefin S, Bhattacharjee M, Islam A. Comparative study of stigma and discrimination among vaccinated and non-vaccinated COVID-19 survivors in Bangladesh BMC infectious diseases 25(1):338 2025 [PMID: 40065223]
  118. Kostinov M, Chuchalin A, Svitich O, Gaynitdinova V, Mashilov K, Kryukova N, Osiptsov V, Tatevosov V, Khromova E, Baranova I, Vlasenko A, Shogenova L, Mekhantseva I, Khrapunova I, Linok A, Kostinov A, Polishchuk V, Poddubikov A. Bacterial lysates in modifying sIgA levels in the upper respiratory tract in COVID-19 patients Scientific reports 15(1):8325 2025 [PMID: 40065113]
  119. Hurst JH, Mohan AA, Dalapati T, George IA, Aquino JN, Lugo DJ, Pfeiffer TS, Rodriguez J, Rotta AT, Turner NA, Burke TW, McClain MT, Henao R, DeMarco CT, Louzao R, Denny TN, Walsh KM, Xu Z, Mejias A, Ramilo O, Woods CW, Kelly MS. Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection Nature communications 16(1):2383 2025 [PMID: 40064870]
  120. Li SS, McGrail K, Rosychuk RJ, Law MR, Hohl CM. Outcomes for people experiencing homelessness with COVID-19 presenting to emergency departments in Canada, compared with housed patients CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 197(9):E236-E243 2025 [PMID: 40064502]
  121. Grygarová D, Havlík M, Adámek P, Horáček J, Juríčková V, Hlinka J, Kesner L. Beliefs in Misinformation About COVID-19 and the Russian Invasion of Ukraine Are Linked: Evidence From a Nationally Representative Survey Study JMIR infodemiology 5:e62913 2025 [PMID: 40063941]
  122. Shao A, Chen K, Johnson B, Miranda S, Xing Q. Ubiquitous News Coverage and Its Varied Effects in Communicating Protective Behaviors to American Adults in Infectious Disease Outbreaks: Time-Series and Longitudinal Panel Study Journal of medical Internet research 27:e64307 2025 [PMID: 40063934]
  123. Patel M, Shamim U, Umang U, Pandey R, Narayan J. SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India PLoS neglected tropical diseases 19(3):e0012918 2025 [PMID: 40063870]
  124. Wang X, Pahwa A, Bausch-Jurken MT, Chitkara A, Sharma P, Malmenäs M, Vats S, Whitfield MG, Lai KZH, Dasari P, Gupta R, Nassim M, Van de Velde N, Green N, Beck E. Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE Advances in therapy 2025 [PMID: 40063213]
  125. Lauring AS, Edson C, Surie D, Dawood FS, Self WH, Lucero-Obusan C, Holodniy M. Genomic Characterization of RSV in the US by Vaccination Status JAMA 2025 [PMID: 40063039]
  126. Adler AL, Waghmare A, Lacombe K, Dickerson JA, L Greninger A, Briggs Hagen M, Pringle K, Fairlie T, Midgely CM, Englund JA. Seroprevalence of SARS-CoV-2 IgG antibodies in children seeking medical care in Seattle, WA June 2020 to December 2022 Microbiology spectrum :e0262524 2025 [PMID: 40062892]
  127. Kida I, Tamura T, Kuroda Y, Fukuhara T, Maeda K, Matsuno K. Application of versatile reverse genetics system for feline coronavirus Microbiology spectrum :e0269224 2025 [PMID: 40062768]
  128. Garcia-Knight MA, Kelly JD, Lu S, Tassetto M, Goldberg SA, Zhang A, Pineda-Ramirez J, Anglin K, Davidson MC, Chen JY, Fortes-Cobby M, Park S, Martinez A, So M, Donovan A, Viswanathan B, Richardson ET, McIlwain DR, Gaudilliere B, Rutishauser RL, Chenna A, Petropoulos C, Wrin T, Deeks SG, Abedi GR, Saydah S, Martin JN, Briggs Hagen M, Midgley CM, Peluso MJ, Andino R. Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections JCI insight 10(5) 2025 [PMID: 40059831]
  129. Seesen M, Sunintaboon P, Limthongkul J, Janhirun Y, Lerdsamran H, Wiriyarat W, Ubol S, Jearanaiwitayakul T. Intranasal Administration of Bivalent RBD Nanoparticles Elicits Strong Systemic Responses That Effectively Block Distal Dissemination of COVID-19 Microbiology and immunology 2025 [PMID: 40059333]
  130. Kingstad-Bakke B, Lee W, Yount BL Jr, Cleven T, Park H, Sullivan JA, Baric RC, Suresh M. Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice Communications biology 8(1):392 2025 [PMID: 40057586]
  131. Oyebanji OA, Yin A, Sundheimer N, Ragavapuram V, Shea P, Cao Y, Chan PA, Nanda A, Tyagi R, Raza S, Mujahid N, Abul Y, Balazs AB, Bosch J, King CL, Klein SL, Gravenstein S, Canaday DH, Wilson BM. COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents Aging clinical and experimental research 37(1):73 2025 [PMID: 40055264]
  132. Tokhanbigli S, Salami Ghaleh S, Rahimian K, Mahmanzar M, Bayat S, Ahangarzadeh S, Moradi B, Mahmanzar R, Wang Y, Oliver BGG, Deng Y. Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19 Frontiers in immunology 16:1435873 2025 [PMID: 40124365]
  133. Kelly M, Given J, Arnott J, Dolk H, Greene RA, Khashan AS, Leonard S, Madigan M, O'Mahony MT, Loane M, Maher GM. Data sources on COVID-19 infection and vaccination in pregnancy on the island of Ireland: strengths, weaknesses, and recommendations for future pandemic preparedness HRB open research 7:77 2024 [PMID: 40110096]
  134. Lundrigan E, Uguccioni S, Hum C, Ahmed N, Pezacki JP. SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways Virology 606:110493 2025 [PMID: 40073498]
  135. Cho J, Lee NK, Kim JY, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ. Trends in the Incidence of Retinal Artery and Vein Occlusion Before and After COVID-19: A National Study in South Korea (2017-2022) American journal of ophthalmology 2025 [PMID: 40058535]
  136. Sanmarchi F, Capodici A, Golinelli D, Lenzi J, Zamparini M, Toth F, De Girolamo G, Stoto MA. Regional variations in Italy's COVID-19 death toll: a descriptive analysis of excess mortality and associated factors from 2020 to 2021 Population health metrics 23(1):9 2025 [PMID: 40055788]
  137. Abdul Rahim NS, Lim XJ, Leong EL, Lim SY, Amri NA, Lim CC, Devesahayam PR. Association of COVID-19 infection and COVID-19 vaccination with idiopathic sudden sensorineural hearing loss in Malaysia: a case-control study BMC public health 25(1):920 2025 [PMID: 40055620]
  138. Gong XY, Wei JC, Zhang LY. Possible perspectives for cardiovascular events following coronavirus disease 2019 vaccination European heart journal 2025 [PMID: 40053691]
  139. Jian Y, Dong S, Zhang Q, Pan J, Hu R, Ding Z, Wu H, Ke S, Chen Z. In vitro inhibitory activity of indole alkaloid derivatives against porcine epidemic diarrhea virus Archives of virology 170(4):67 2025 [PMID: 40053140]
  140. Zaidi S, Qayyum HA, Qayyum IA, Khan Z, Islam T, Ahmed N, Hopkins KL, Sommers T, Akhtar S, Khan SA, Javed S, Ikram A, Akhtar H. COVID-19 vaccines side effects among the general population during the pandemic: a cross-sectional study Frontiers in public health 13:1420291 2025 [PMID: 40115337]
  141. Lopes da Silva VG, Schmitz GJH, Sullivan KE, Barbate J, de Haro Azinar MI, Aranda CS, de Moraes-Pinto MI. Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls Frontiers in immunology 16:1538453 2025 [PMID: 40114918]
  142. Alsoubani M, Chow J. Navigating Coronavirus Disease 2019 in Immunocompromised Populations: Evolving Risk Factors, Treatment, and Outcomes Infectious disease clinics of North America 2025 [PMID: 40055107]
  143. Gordon JL, Boespflug EL, Coleman A, Taylor K, Cohen N, Yoon IK, Cassetti MC. Development of broadly protective coronavirus vaccines: A joint NIAID-CEPI workshop report Vaccine 54:126909 2025 [PMID: 40054139]
  144. Shoshi HR, Basher AK, Pyash AS, Hossain MK, Chowdhury F, Hassan MZ. Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh BMC health services research 25(1):346 2025 [PMID: 40050921]
  145. Santigli E, Lindner M, Kessler HH, Jakse N, Fakheran O. Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis Scientific reports 15(1):7848 2025 [PMID: 40050642]
  146. Debie Y, Garcia-Fogeda I, Willem L, Roelant E, Verbruggen L, Vanhoutte G, Croes L, Vulsteke C, Demey W, Lybaert W, Hanssens M, Bols A, Van Ongeval J, De Becker A, Jansens H, Goossens ME, Janssens A, Prenen H, Anguille S, Peeters M, van Dam PA, Hens N, Abrams S, Vandamme T. Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients Scientific reports 15(1):7858 2025 [PMID: 40050359]
  147. Vatanparast A, Daghigh F, Akbari H. Sinopharm COVID-19 Vaccination during Pregnancy Triggers Thyroid Stimulating Hormone Levels in Newborns American journal of perinatology 2025 [PMID: 40049595]
  148. Kwan AT, Vargo J, Kurtz C, Panditrao M, Hoover CM, León TM, Rocha D, Wheeler W, Jain S, Pan ES, Shete PB. The integration of health equity into policy to reduce disparities: Lessons from California during the COVID-19 pandemic PloS one 20(3):e0316517 2025 [PMID: 40048417]
  149. de Oliveira Guardalini LG, Moura Dias F, Omae Camalhonte S, Leme J, Consoni Bernardino T, Soares Sposito F, Dias E, Mancini Astray R, Tonso A, Attie Calil Jorge S, Fernández Núñez EG. Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system Biotechnology letters 47(2):32 2025 [PMID: 40045076]
  150. Blizard GS, Dwivedi G, Pan YG, Hou C, Etersque JM, Said H, Chevrier A, Lavertu M, Ni H, Davis B, Tam Y, Cao Q, Mach RH, Weissman D, Alameh MG, Sellmyer MA. Monitoring mRNA vaccine antigen expression in vivo using PET/CT Nature communications 16(1):2234 2025 [PMID: 40044669]
  151. Fujitani M, Lu X, Shinnakasu R, Inoue T, Kidani Y, Seki NM, Ishida S, Mitsuki S, Ishihara T, Aoki M, Suzuki A, Takahashi K, Takayama M, Ota T, Iwata S, Shibata RY, Sonoyama T, Ariyasu M, Kitano A, Terooatea T, Kelly Villa J, Yamashita K, Yamasaki S, Kurosaki T, Omoto S. Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study Frontiers in immunology 16:1550279 2025 [PMID: 40109335]
  152. Roederer AL, Cao Y, Li CJ, Lim E, Canaday DH, Gravenstein S, Balazs AB. SARS-CoV-2 Fusion Peptide-Directed Antibodies Elicited by Natural Infection Mediate Broad Sarbecovirus Neutralization medRxiv : the preprint server for health sciences 2025 [PMID: 40093263]
  153. Ward T, Paton RS, Overton CE, Mellor J, Aziz NA, Charlett A, Fyles M. Understanding the Effectiveness of the Comirnaty Monovalent and Bivalent Vaccines During the Winter Coronavirus (COVID-19) Infection Survey The Journal of infection :106461 2025 [PMID: 40054670]
  154. Sardeshmukh S, Deshmukh V, Gupta V, Godse V, Gujar S, Kulkarni S, Dalvi S, Sardeshmukh N, Sardeshmukh B, Bhuvad S, Chavan S, Awalkanthe V, Datar S, Shingte A, Salunkhe A, Salunkhe A, Nabar S, Deshpande D, Dafare T. Efficacy of Ayurvedic treatment given to cancer patients in the prevention of COVID-19 - A Retrospective Cohort Study at Integrated Cancer Treatment and Research Centre, Wagholi Journal of Ayurveda and integrative medicine 16(2):101045 2025 [PMID: 40049054]
  155. Angeli L, Caetano CP, Franco N, Coletti P, Faes C, Molenberghs G, Beutels P, Abrams S, Willem L, Hens N. Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis Nature communications 16(1):2230 2025 [PMID: 40044649]
  156. Patel NJ, Srivatsan S, Kowalski EN, King A, Wang X, Vanni KM, Qian G, Hanberg JS, Bade KJ, Saavedra AA, Mueller KT, Hang B, Williams ZK, Johnson C, Negron M, Sparks JA, Wallace ZS. Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022-2024): a retrospective cohort study RMD open 11(1) 2025 [PMID: 40044572]
  157. Alric L, Brusq C, Migueres M, Faure S, Lebray P, Viallard JF, Chauveau D, Sailler L, Bérard E, Pugnet G, Cacoub P. Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial Lupus science & medicine 12(1) 2025 [PMID: 40044500]
  158. Beckerman JK, Yaghi O, Nassereddine S. Acquired haemophilia A following COVID-19 vaccine BMJ case reports 18(3) 2025 [PMID: 40044482]
  159. Carreño JM, Lerman B, Singh G, Abbad A, Yellin T, Ehrenhaus J, Fried M, Nardulli JR, Kang HM, Mulder LCF, Gleason C, Srivastava K, Simon V, Krammer F. XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies mBio :e0360724 2025 [PMID: 40042313]
  160. Yang S, Li H, Liu F. Commentary: Inactivated rabies virus vectored MERS-Coronavirus vaccine induces protective immunity in mice, camels, and alpacas Frontiers in immunology 16:1549481 2025 [PMID: 40103811]
  161. Koul M, Kaushik S, Singh K, Sharma D. VITALdb: to select the best viroinformatics tools for a desired virus or application Briefings in bioinformatics 26(2) 2025 [PMID: 40063348]
  162. Xu X, Ding W, Song H, Wang D. Unique skin nodules following COVID-19 vaccination: a case report of cutaneous plasmacytosis and review of the literature Virology journal 22(1):57 2025 [PMID: 40038708]
  163. Huiberts AJ, de Bruijn S, Andeweg SP, Hoeve CE, Schipper M, de Melker HE, van de Wijgert JH, van den Hof S, van den Wijngaard CC, Knol MJ. Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands Nature communications 16(1):1923 2025 [PMID: 40038286]
  164. Xue Y, Hou X, Zhong Y, Zhang Y, Du S, Kang DD, Wang L, Wang C, Li H, Wang S, Liu Z, Tian M, Guo K, Cao D, Deng B, McComb DW, Purisic E, Dai J, Hamon P, Brown BD, Tsankova NM, Merad M, Irvine DJ, Weiss R, Dong Y. LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment Nature communications 16(1):2198 2025 [PMID: 40038251]
  165. Ao D, Peng D, He C, Ye C, Hong W, Huang X, Lu Y, Shi J, Zhang Y, Liu J, Wei X, Wei Y. A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants Molecular biomedicine 6(1):13 2025 [PMID: 40035925]
  166. Hu H, Zhang Y, Zheng H, Zhao X, Ran W, Liao C, Lu M, Zhou J, Song X, Ye L. Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response Journal of virology :e0232324 2025 [PMID: 40035515]
  167. Ma Z, Li Z, Li Y, Zhao X, Zheng C, Li Y, Guo X, Xu L, Zheng Z, Liu G, Zheng H, Xiao S. Changes in the motifs in the D0 and SD2 domains of the S protein drive the evolution of virulence in enteric coronavirus porcine epidemic diarrhea virus Journal of virology :e0209224 2025 [PMID: 40035514]
  168. Ma Y, Du Y, Yang J, Wang H, Lin X. Effect of Inactivated Vaccines Against SARS-CoV-2 on Immunogenicity Outcome Disaster medicine and public health preparedness 19:e50 2025 [PMID: 40033891]
  169. Gligorov M, Lebrun-Vignes B, Masmoudi K, Vial T, Junot H, Pourcher V, Demeret S, Weiss N, Bihan K. Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysis Therapie 2025 [PMID: 40090811]
  170. Lee M, Kwon JS, Kim SH, Woo S, Oh SS. Electrochemical pan-variant detection of SARS-CoV-2 through host cell receptor-mimicking molecular recognition Biosensors & bioelectronics :117311 2025 [PMID: 40044551]
  171. Wachter BT, Xu Q, Shi L, Burbelo PD, Myint-Hpu K, Schwartzberg PL, Rehman MT, Dewar RL, Boswell KL, Koup RA, Oguz C, Imberti L, Bellusci L, Pourhashemi S, Khurana S, Manthiram K, Notarangelo LD, Delmonte OM. Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster The Journal of allergy and clinical immunology 2025 [PMID: 40044048]
  172. Peixoto de Miranda ÉJF, Calado RT, Boulos FC, de Sousa Moreira JA, Machado FF, Almeida MAALDS, Da Rocha MCO, Infante V, Mercer LD, Hjorth R, Scharf R, White J, Polyak C, Raghunandan R, García-Sastre A, Sun W, Palese P, Krammer F, Innis B, Pereira CG, Kallas EG. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil Vaccine 52:126680 2025 [PMID: 40037239]
  173. Zhao T, Xu Q, Cai X, Wang M, Ao L, Wei T, Yang H, Zhang S, Zhang X, Jin S, Wang X, Feng X, Zhao J, Wu Y, Yang J, Cui F. Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis Vaccine 53:126933 2025 [PMID: 40037126]
  174. Kadoi K, Toba J, Uehara A, Isoda N, Sakoda Y, Iwamoto E. Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2 Vaccine 53:126951 2025 [PMID: 40037125]
  175. Jiang M, Liu R, Yao W, Li S, Liang X, Zhang H. Precise control model of the epidemic: a cross-sectional study Nucleosides, nucleotides & nucleic acids :1-14 2025 [PMID: 40033645]
  176. Keskin S, Ergör G. Excess Mortality in Türkiye during 2020-2022: Regional and Time-Based Analysis Balkan medical journal 42(2):130-137 2025 [PMID: 40033635]
  177. Mehta A, Pant A. Post coronavirus-disease-vaccination immune reconstitution inflammatory syndrome in tuberculosis treatment: a case report Journal of medical case reports 19(1):93 2025 [PMID: 40033413]
  178. Soleimani M, Jalilvand A. Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness Scientific reports 15(1):7450 2025 [PMID: 40032988]
  179. Kepp KP, Cristea I, Muka T, Ioannidis JPA. COVID-19 advocacy bias in the BMJ: meta-research evaluation BMJ open quality 14(1) 2025 [PMID: 40032597]
  180. Moreira-Soto A, Beuchel C, Tabares X, Wulf B, Gade N, Fischer C, Knipper M, Aigner A, Drexler JF. Socioeconomic determinants potentially underlying differential global SARS-CoV-2 testing capacity: an ecological study BMJ open 15(3):e090804 2025 [PMID: 40032387]
  181. Lu J, Tang Y, Li H, Chen X, Qin P, Xu J, Li W, Chen L. Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds International journal of molecular sciences 26(5) 2025 [PMID: 40076865]
  182. Courtemanche O, Blais-Lecours P, Lesage S, Chabot-Roy G, Coderre L, Blanchet MR, Châteauvert N, Lellouche F, Marsolais D. Exploratory analyses of leukocyte responses in hospitalized patients treated with ozanimod following a severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection Immunology and cell biology 2025 [PMID: 40025871]
  183. Liu J, Li N, Wang B, Zhao W, Zhi J, Jia X, Jia Y, Tie Y. SARS-CoV-2 Infection Aggravates Physical and Mental Health in Cancer Patients Compared to Co-Living Individuals Cancer medicine 14(6):e70795 2025 [PMID: 40129313]
  184. Guang Y, Lina L, Hui L. Seroprevalence of SARS-CoV-2 Antibody Before and After Both Vaccination and Natural Infection in China Immunity, inflammation and disease 13(3):e70184 2025 [PMID: 40125836]
  185. Chan JCH, Chan EY, Cheng SMS, Leung D, Ho FT, Tong PC, Lai WM, Lee MHL, Chim S, Tsang LCH, Kwan TC, Cheuk YC, Wang M, Wong HHW, Lee AMT, Li WY, Chan SM, Tam IYS, Lam JHY, Zhang K, Tu W, Peiris M, Rosa Duque JS, Lau YL, Ma AL. Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases Clinical kidney journal 18(3):sfaf052 2025 [PMID: 40123970]
  186. Ürün Ünal B, İyit N, Akdoğan Y, Gök Erdoğan B, Altıparmak YD. Psychological and Burnout Effects of the COVID-19 Pandemic on Individuals Immunity, inflammation and disease 13(3):e70181 2025 [PMID: 40116338]
  187. Vu M, Li J, Hong K, Kaminski JW, Cho BH, Kang Y. An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID-19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data Cancer medicine 14(6):e70761 2025 [PMID: 40116295]
  188. Grisanti SG, Garbarino S, Bellucci M, Schenone C, Candiani V, Di Lillo S, Campi C, Barisione E, Aloè T, Tagliabue E, Serventi A, Pesce G, Massucco S, Cabona C, Lechiara A, Uccelli A, Schenone A, Piana M, Benedetti L. Neurological long COVID in the outpatient clinic: Is it so long? European journal of neurology 32(3):e16510 2025 [PMID: 40115993]
  189. Rice A, Gonzalez G, Carr M, Dean J, O'Byrne E, Aarts L, Vennema H, Banka W, Bennett C, Cleary S, Domegan L, O'Donnell J, O'Leary M, Goya S, Presser L, Meijer A, Martin G, Sawa H, Waters A, De Gascun C, Hare D. Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic Microbial genomics 11(3) 2025 [PMID: 40096248]
  190. Berkell M, Górska A, Smet M, Bachelet D, Gentilotti E, Guedes M, Franco-Yusti AM, Mazzaferri F, Forero EL, Matheeussen V, Visseaux B, Palacios-Baena ZR, Caroccia N, Florence AM, Charpentier C, van Leer C, Giannella M, Friedrich AW, Rodríguez-Baño J, Ghosn J, Kumar-Singh S, Laouénan C, Tacconelli E, Malhotra-Kumar S. Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 30(10) 2025 [PMID: 40084424]
  191. Vukovikj M, Melidou A, Nannapaneni P, Normark T, Kraus A, Broberg EK. Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 30(10) 2025 [PMID: 40084420]
  192. Arkell P, Tanesi MY, Martins N, Gomes N, Oakley T, Solano V, David M, Amaral S, Sheridan SL, Yip TW, Draper ADK, Sarmento N, Soares da Silva E, Alves L, Nicholson S, Stambos V, Pedrina K, Freitas C, de Neri Machado F, Gusmão CA, da Costa Barreto I, Fancourt NSS, Macartney K, Yan J, Francis JR. A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste The Lancet regional health. Southeast Asia 34:100525 2025 [PMID: 40084157]
  193. Taher MK, Salzman T, Banal A, Morissette K, Domingo FR, Cheung AM, Cooper CL, Boland L, Zuckermann AM, Mullah MA, Laprise C, Colonna R, Hashi A, Rahman P, Collins E, Corrin T, Waddell LA, Pagaduan JE, Ahmad R, Jaramillo Garcia AP. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence Health promotion and chronic disease prevention in Canada : research, policy and practice 45(3):112-138 2025 [PMID: 40073162]
  194. van den Dijssel J, Konijn VAL, Duurland MC, de Jongh R, Koets L, Veldhuisen B, Raaphorst H, Turksma AW, Freen-van Heeren JJ, Steenhuis M, Rispens T, van der Schoot CE, van Ham SM, van Lier RAW, van Gisbergen KPJM, Ten Brinke A, van de Sandt CE. Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8(+) T Cell Responses European journal of immunology 55(3):e202451565 2025 [PMID: 40071711]
  195. Azanza JR, González Del Castillo JM, Ferrando R, Molero JM, Soriano A, Peral C, de Lossada A, Bellmunt A, Garí C, Mugwagwa T, López-Gómez V. Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain Journal of medical virology 97(3):e70288 2025 [PMID: 40062871]
  196. Liu S, Liu P, Lu Q, Shen Y, Zhang L, Liang Z, Yu Y, Huang W, Wang Y. The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS-CoV-2 Omicron Variants Journal of medical virology 97(3):e70242 2025 [PMID: 40062404]
  197. Wen CK, Yang PH, Liu HL, Yeh IJ, Su CY. Impact of Receiving Coronavirus Disease 2019 (COVID-19) Vaccination on Work Stress of Healthcare Workers: A Cross-Sectional Study Journal of acute medicine 15(1):19-29 2025 [PMID: 40061305]
  198. Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC. Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024 Influenza and other respiratory viruses 19(3):e70081 2025 [PMID: 40059069]
  199. Al Shabeeb RQ, Lee E, El Shatanofy M, Pashai E, Benjenk I, Sherman M, Heinz E, Yamane D, Borum ML. Factors Affecting Gastroenterologists' Fear When Performing Endoscopies during the COVID Pandemic: Results of a US National Survey Southern medical journal 118(3):181-183 2025 [PMID: 40031768]
  200. Islam MM, Azarian T, Agarwal S, Ali S. Capturing the Impact of Vaccination and Human Mobility on the Evolution of COVID-19 Pandemic IEEE journal of biomedical and health informatics 29(3):2318-2327 2025 [PMID: 40030417]
  201. Tarulli CM, Ma X, Chokar K, Vozoris NT, Clancy MS, Faughnan ME. Health outcomes following COVID-19 infection and vaccination in hereditary hemorrhagic telangiectasia Orphanet journal of rare diseases 20(1):94 2025 [PMID: 40025608]
  202. Kumar D, Gaikwad K, Gunnale R, Vishwakarma S, Shukla S, Srivastava S, Gopal J, Vaidya B, Saraf A, Gurjar R, Kaviraj S, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S. Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19 NPJ vaccines 10(1):42 2025 [PMID: 40025095]
  203. Todoroki Y, Nakayamada S, Miyagawa I, Kubo S, Yoshioka K, Satoh M, Tanaka Y. Spontaneous Remission in a Patient with Anti-OJ Autoantibodies-positive Anti-synthetase Syndrome Following SARS-CoV-2 Infection and mRNA Vaccination: A Case Report Internal medicine (Tokyo, Japan) 2025 [PMID: 40024740]
  204. Bi K, Bandekar SR, Bouchnita A, Fox SJ, Meyers LA. Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024 Emerging infectious diseases 31(3):636-638 2025 [PMID: 40023827]
  205. Parums DV. Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials Medical science monitor : international medical journal of experimental and clinical research 31:e948672 2025 [PMID: 40022523]
  206. Cong X, Tong F, Liu H, Zhu Y, Tan N, Gu F, Wang H, Cong F. Establishment of a novel double-antibody sandwich fluorescence microsphere immunochromatographic test strip for rapid detection of swine acute diarrhea syndrome coronavirus (SADS-CoV) infection Frontiers in cellular and infection microbiology 15:1461845 2025 [PMID: 40093537]
  207. Fahnøe U, Feng S, Underwood AP, Jacobsen K, Ameri A, Blicher TH, Sølund CS, Rosenberg BR, Brix L, Weis N, Bukh J. T cell receptor usage and epitope specificity amongst CD8(+) and CD4(+) SARS-CoV-2-specific T cells Frontiers in immunology 16:1510436 2025 [PMID: 40092978]
  208. Herdiana Y. Nanoparticles of natural product-derived medicines: Beyond the pandemic Heliyon 11(4):e42739 2025 [PMID: 40083991]
  209. Choi SI, Jung WJ, Jeong Y, Park S, Kim BK, Lee SY, An H, Lee EJ. COVID-19 infection and pulmonary sarcoidosis: a systematic review and meta-analysis of morbidity, severity and mortality Journal of thoracic disease 17(2):744-752 2025 [PMID: 40083482]
  210. Ocan M, Katusiime M, Kyabayinze D, Kwesiga B, Ayebare R, Nakasendwa S, Mbabazi L, Bosa HK, Nansiiro H, Sanger D, Tayebwa M, Tusiime B, Kiragga A, Kakooza F, Gonese E, Shaweno T, Dereje N, Fallah MP, Ario AR. COVID-19 vaccine uptake and associated factors among health workers in Kampala city, Uganda Journal of public health in Africa 16(1):720 2025 [PMID: 40083474]
  211. Tran L, Cucé F, Thanh An N, Dila KAS, Nam NH, Cat DLN, Jun LW, Ansar F, Abdallh F, Vo A, Huy NT. A content review of COVID-19-related apps used in Vietnam Journal of infection in developing countries 19(2):208-220 2025 [PMID: 40063748]
  212. Ignatenko NA, Trinh H, Wagner AM, Gerner EW, Bime C, Hsu CH, Besselsen DG. Preclinical evaluation of the efficacy of α-Difluoromethylornithine and Sulindac against SARS-CoV-2 infection bioRxiv : the preprint server for biology 2025 [PMID: 40060444]
  213. Su J, Zhang J, Feng X, Liu J, Gao S, Liu X, Yang M, Chen Z. A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development Molecular therapy : the journal of the American Society of Gene Therapy 2025 [PMID: 40022448]
  214. Giombini E, Schiavoni I, Ambrosio L, Lo Presti A, Di Martino A, Fiore S, Leone P, Fortunato F, Prato R, Fedele G, Palamara AT, Stefanelli P. JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition BMC infectious diseases 25(1):291 2025 [PMID: 40022017]
  215. Tembo T, Heilmann E, Kabamba BM, Fwoloshi S, Kalenga K, Chilambe F, Siwinga M, Rutagwera MR, Musunse M, Kangale C, Yingst S, Yadav R, Savory T, Gutman JR, Sikazwe I, Mulenga LB, Moore CB, Hines JZ. Implementing SARS-CoV-2 routine surveillance in antenatal care in Zambia, 2021-2022: best practices and lessons learned BMC public health 25(1):813 2025 [PMID: 40021963]
  216. Turcu-Stiolica A, Boicea AR, Nechita F, Surugiu R, Dumitra GG, Oancea CN, Pîrlog MC. Development and validation of a questionnaire to measure COVID-19 vaccine hesitancy within the Romanian industrial laborers Frontiers in public health 13:1482778 2025 [PMID: 40084211]
  217. Almalki MJ, Alotaibi AA, Jabour AM, Elamin A, Hetany WA, Adam HAM, Moafa HN, Alamer AS, Alsharif A, Almalki SM. Public perception of COVID-19 in Saudi Arabia during the Omicron wave: recommendations for policy improvement Frontiers in public health 13:1419891 2025 [PMID: 40084201]
  218. Ng HY, Liao Y, Cheung CL, Zhang R, Chan KH, Seto WK, Leung WK, Hung IFN, Lam TTY, Cheung KS. Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine immunogenicity Frontiers in immunology 16:1534787 2025 [PMID: 40083550]
  219. Vuilleumier N, Pagano S, Lorthe E, Lamour J, Nehme M, Juillard C, Barbe R, Posfay-Barbe KM, Guessous I, Stringhini S, L'Huillier AG. Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children Frontiers in immunology 16:1521299 2025 [PMID: 40079006]
  220. Mandal S, Chanu WP, Natarajaseenivasan K. Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach Frontiers in immunology 16:1442101 2025 [PMID: 40079004]
  221. McCullough PA, Hulscher N. Risk stratification for future cardiac arrest after COVID-19 vaccination World journal of cardiology 17(2):103909 2025 [PMID: 40061285]
  222. Bullock A, Dalton AF, Stockwell MS, McLaren SH, Sano E, Nguyen HQ, Rao S, Asturias E, Lutrick K, Ellingson KD, Maldonado Y, Mellis AM, Smith-Jeffcoat SE, Grijalva CG, Talbot HK, Rolfes MAR, Biddle JE, Zhu Y, Ledezma K, Pryor K, Valdez de Romero A, Vargas C, Petrie JG, Floris-Moore M, Bowman N. Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 40036243]
  223. Suzuki J, Mizuno T, Takahashi S, Imai H, Itagaki H, Akaba T, Yoshida M, Endo S. The relationship between severe acute respiratory syndrome coronavirus 2 omicron variant epidemic and acute myocardial infarction: A self-controlled case series study Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31(4):102666 2025 [PMID: 40021005]
  224. Wang X, Yang X, Zhang X, Yan H, Jin J, Ma Z, Duan J, Zhang G, Huang T, Li Y, Wu H, Zhang T, Zhu A, Jin C, Song X, Su B. Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine Frontiers in immunology 16:1554409 2025 [PMID: 40070834]
  225. Diaz M, Mikulski Z, Leaman D, Gandarilla A, Da Silva N, Verkoczy A, Zhang J, Verkoczy L. SARS-CoV-2 spike peptide analysis reveals a highly conserved region that elicits potentially pathogenic autoantibodies: implications to pan-coronavirus vaccine development Frontiers in immunology 16:1488388 2025 [PMID: 40070822]
  226. Ren M. Coronavirus Disease 2019 Case Series in China: Sequelae and Effectiveness of Vaccination and Antiviral Drugs Infection and drug resistance 18:1125-1133 2025 [PMID: 40027918]
  227. Sun DS, Lien TS, Chang HH. Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever International journal of molecular sciences 26(5) 2025 [PMID: 40076527]
  228. Sepúlveda-Delgado J, Llorente L, Hernández-Doño S. A Comprehensive Review of Fc Gamma Receptors and Their Role in Systemic Lupus Erythematosus International journal of molecular sciences 26(5) 2025 [PMID: 40076476]
  229. Akther S, Samiha F, Sony SA, Haque MA, Hasnat MA, Islam SMS, Ahmed S, Abdullah-Al-Shoeb M. Assessment of serum biomarker changes following the COVID-19 pandemic and vaccination: a cohort study in Sylhet, Bangladesh Frontiers in public health 13:1435930 2025 [PMID: 40061468]
  230. Alessandria M, Malatesta G, Di Palmo G, Cosentino M, Donzelli A. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data F1000Research 13:886 2024 [PMID: 40028449]
  231. Tsang HW, Chua GT, Tung KTS, Wong RSM, Tsao SSL, Wong JSC, Tung JYL, Kwok JSY, Yam JCS, Chan GCF, To KKW, Wong ICK, Leung WH, Kwan MYW, Ip P. The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis Frontiers in immunology 16:1501609 2025 [PMID: 40046048]
  232. Midzi N, Haruzivishe C, Sembuche S, Mutsaka-Makuvaza MJ, Ayebare R, Mbabazi L, Nakasendwa S, Muwonge T, Mateta C, Madanhire T, Chaibva C, Gwatiringa C, Mutsaka K, Mawerewere V, Phiri I, Gonese E, Shaweno T, Dereje N, Tajudeen R, Fallah M, Dobbie M. Barriers and enhancers to COVID-19 vaccination among healthcare workers in Zimbabwe Journal of public health in Africa 16(1):719 2025 [PMID: 40083473]
  233. Zhuang Q, Wang H, Bai Q, Liang J. The impact of the relationship between government and pharmaceutical enterprises on social contribution during the public health emergency: an empirical study Frontiers in public health 13:1494922 2025 [PMID: 40041178]
  234. Zayou L, Prakash S, Vahed H, Dhanushkodi NR, Quadiri A, Belmouden A, Lemkhente Z, Chentoufi A, Gil D, Ulmer JB, BenMohamed L. Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19 Frontiers in immunology 16:1503954 2025 [PMID: 40040708]
  235. Raimondi V, Storti P, Vescovini R, Franceschi V, Toscani D, Notarfranchi L, Dalla Palma AB, Iannozzi NT, Minesso S, Scita M, Lungu O, Dessena M, Donofrio G, Giuliani N. Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients Frontiers in immunology 16:1532947 2025 [PMID: 40040701]
  236. Levy ME, Chilunda V, Heaton PR, McKeen D, Goldman JD, Davis RE, Schandl CA, Glen WB, McEwen LM, Cirulli ET, Wyman D, Dei Rossi A, Dai H, Isaksson M, Washington NL, Basler T, Tsan K, Nguyen J, Ramirez J, Sandoval E, Lee W, Lu J, Luo S. XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants Frontiers in immunology 16:1470609 2025 [PMID: 40034704]
  237. Wang C, Tang X, Jiang C, Zhang Y, Han B, Sun Y, Guo J, Peng H, Wang Z, Wang Y, Zhang J, Zhang Y, Jiang C. Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats Frontiers in immunology 16:1530736 2025 [PMID: 40034698]
  238. Osaghae EO, Sirek G, Roberson T, Chandler M, Childs A, Crespo-Bosque M, Curry G, Dhand A, Dollear M, Eggelston A, Ezeh N, Fleurissaint D, Garrett D, Granville G, Jean-Jacques M, Losina E, Milaeger H, Muhammad L, Nelson MA, Nosamiefan C, Ojikutu B, Pillai N, Son MB, Toussaint MJ, Valle A, Williams JN, York M, Mancera-Cuevas K, Feldman CH, Ramsey-Goldman R. Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions Frontiers in public health 12:1493331 2024 [PMID: 40034470]
  239. Russo C, Otero A, Uranga M, Seery V, Raiden S, Algieri S, De Carli N, Borda M, Albistur MF, Heinitz L, Marcó Del Pont M, Pardini M, Budano G, Alvarez L, Simaz N, Merhar C, Quintana MC, Garbini C, Portela LA, Pereira MS, Ferrero F, Geffner J, Arruvito L. Immunological memory to COVID-19 vaccines in immunocompromised and immunocompetent children Frontiers in cellular and infection microbiology 15:1527573 2025 [PMID: 40034392]
  240. Ohsaki Y, Sasaki T, Umekage Y, Yanada H, Ishikawa M, Yoshida R. Real-World Treatment Outcomes in the First and Subsequent Coronavirus Disease 2019 (COVID-19) Hospital Clusters Cureus 17(2):e78981 2025 [PMID: 40099057]
  241. Jamaati H, Karimi S, Arshi S, Zahraei SM, Panahi Y, Nouri F, Hajimoradi M, Hasanzade A, Mokhtari M, Tayeri K, Abedini A, Mohamadnia A, Tabarsi P, Sharif-Kashani B, Marjani M, Rashid Farokhi F, Hashemian SMR, Hosseini-Baharanchi FS, Norizadeh M, Astani B, Noorali S, Ahmadi F, Shafaghi S, Ghorbani F. Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis Frontiers in immunology 16:1504973 2025 [PMID: 40028315]
  242. Molinelli E, De Simoni E, Gambini D, Maurizi A, Dragonetti ML, Belleggia S, Rizzetto G, Offidani A, Simonetti O. Viral infection as a trigger of hidradenitis suppurativa disease activity: the role of SARS-CoV-2 infection in acute flares European journal of dermatology : EJD 35(1):38-42 2025 [PMID: 40110819]
  243. Wang M, Liu C, Fan Q, Sun Y, Tang S, Guo H, Zhou B, Wang H, Ge X, Zhang Z, Ju B. Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies Journal of immunology (Baltimore, Md. : 1950) 214(2):278-289 2025 [PMID: 40073246]
  244. Kurmangaliyeva SS, Madenbayeva AM, Urazayeva ST, Bazargaliyev YS, Kudabayeva KI, Kurmangaliyev KB. The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status Iranian journal of medical sciences 50(2):61-68 2025 [PMID: 40026299]
  245. Cunha B, Gil P, Murta A, Hipólito-Fernandes D, Costa L. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Following SARS-CoV-2 Vaccination Cureus 17(1):e78286 2025 [PMID: 40026947]
  246. Mariani M, Bagnasco F, Sticchi C, Spiazzi R, Giberti I, Icardi G, Castagnola E. Evolution of SARS-CoV-2 epidemics in pediatric population in Liguria (North-west Italy) from March 2020 to December 2022: what could we have learned? Journal of preventive medicine and hygiene 65(4):E483-E490 2024 [PMID: 40026422]
  247. Yang W, Wang F, You Y, Fang Z, Wang X, Mei X. Optimizing vaccination sites for infectious diseases based on heterogeneous travel modes in multiple scenarios Geospatial health 20(1) 2025 [PMID: 40126383]
  248. Al-Huraibi A, Amer S, Blanford J. Prioritizing the location of vaccination centres during the COVID-19 pandemic by bike in the Netherlands Geospatial health 20(1) 2025 [PMID: 40034056]
  249. Arashiro T, Berba RP, Calayo JP, Kris M, Garcia RM, Suzuki S, Dungog C, Rivera J, Malijan GM, Agrupis KA, Salazar MJ, Salazar MA, Shin J, Hibberd M, Ariyoshi K, Smith C. Sociobehavioural factors associated with SARS-CoV-2 infection and COVID-19 vaccine effectiveness against medically attended, symptomatic SARS-CoV-2 infection in the Philippines: a prospective case-control study (FASCINATE-P study) Western Pacific surveillance and response journal : WPSAR 16(1):1-12 2025 [PMID: 40034498]
  250. Sinha N, Patle S. YouTube Hindi Videos Proved to be a Valid and Reliable Source of Health Information: A Case Study of COVID-19 Vaccine Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 50(1):169-174 2025 [PMID: 40124832]
  251. Qiao P, Yue C, Peng W, Liu K, Huo S, Zhang D, Chai Y, Qi J, Sun Z, Gao GF, Wu G, Liu J. Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2 Journal of immunology (Baltimore, Md. : 1950) 214(1):115-129 2025 [PMID: 40073263]
  252. Lins MP, Dos Santos Reis MD. Age-Related Thymic Involution Advances in experimental medicine and biology 1471:285-299 2025 [PMID: 40067592]
  253. Vasileia E, Koulierakis G, Fouskas T, Liarigkovinou A. Health Literacy and Acceptance of COVID-19 Preventive Measures and Vaccination in the European Union: A Scoping Review Health literacy research and practice 9(1):e46-e55 2025 [PMID: 40064011]
  254. Kaya H, Tani H, Itamochi M, Oishi K. [Detection of neutralizing antibody against SARS-CoV-2 in a patient with X-linked agammaglobulinemia receiving immunoglobulin replacement therapy] [Rinsho ketsueki] The Japanese journal of clinical hematology 66(2):130-132 2025 [PMID: 40044175]
  255. Rai S, Tripathi S. Comparative efficacy of leading COVID-19 vaccines: A network meta-analysis The Indian journal of medical research 161(1):9-20 2025 [PMID: 40036106]
  256. Morales-Bayuelo A, Sánchez-Márquez J, Vivas-Reyes R, Kaya S. Study anti-viral drugs for their efficiency against multiple SARS CoV-2 drug targets within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks F1000Research 13:270 2024 [PMID: 40104088]
  257. Enghida RT, Hidru TH. Knowledge, attitude, and perception on COVID-19 vaccine acceptance: cross-sectional study among Eritrean refugees in Kampala The Pan African medical journal 49:103 2024 [PMID: 40093344]
  258. Parsi AO, Verne GN, Jiang Y, Theus SA, Sullivan J, Zhou Q. SARS-CoV-2 Infection, Vaccination, and Irritable Bowel Syndrome in Veterans: A Cross-Sectional Study International journal of gastroenterology (New York, N.Y.) 8(2):76-84 2024 [PMID: 40130268]
  259. Ye F, Wang N, Guan Q, Wang M, Sun J, Zhai D, Huang B, Zhao Y, Tan W. Rapid generation and characterization of recombinant HCoV-OC43-VR1558 infectious clones expressing reporter Renilla luciferase Biosafety and health 6(6):350-360 2024 [PMID: 40078980]
  260. Priya SP, Rao P, Padmanabhan V, Chaitanya NCSK. Principles and Therapeutics of Yajna Journal of pharmacy & bioallied sciences 16(Suppl 5):S4271-S4283 2024 [PMID: 40061654]
  261. Yang C, Yu Y, Peng Q, Song J, Sun B, Shi Y, Ding Q. Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro Biosafety and health 6(5):270-278 2024 [PMID: 40078736]
  262. Liu J, Wong G, Li H, Yang Y, Cao Y, Li Y, Wu Y, Zhang Z, Jin C, Wang X, Chen Y, Su B, Wang Z, Wang Q, Cao Y, Chen G, Qian Z, Zhao J, Wu G. Biosafety and immunology: An interdisciplinary field for health priority Biosafety and health 6(5):310-318 2024 [PMID: 40078733]
  263. Jiang Q, Wu X, Dong F, Qiao S, Shi Q, Jian C, Chen C, Zhou J, Wang Y, Huang W. Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population Biosafety and health 6(5):279-285 2024 [PMID: 40078732]
  264. Afroze F, Begum MN, Ahmed T, El Arifeen S, Rahman MZ, Rahman AE, Mahfuz M, Kabir MF, Kabir A, Amin R, Uddin MS, Asaduzzaman M, Hasnat MA, Islam K, Sharif M, Hossain R, Jahan Y, Rahman M, Chisti MJ. Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh Journal of global health 14:05009 2024 [PMID: 40057834]
  265. Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X, Zhang C, Tang N, Xu Z, Guo Y, Lu R, Zhou D. Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines Biosafety and health 6(3):153-164 2024 [PMID: 40078728]
  266. Qiu C, Peng B, Xiao C, Chen P, Mao L, Shi X, Zhang Z, Lv Z, Lv Q, Zhang X, Li J, Huang Y, Hu Q, Chen G, Zou X, Liang X. A novel method for identifying SARS-CoV-2 infection mutants via an epitope-specific CD8(+) T cell test Biosafety and health 6(3):143-152 2024 [PMID: 40078724]
  267. Astasio O, Castillo-Cano B, Delgado BS, Riefolo F, Gini R, Martín-Merino E. The Validation Of COVID-19 Information In The Pharmacoepidemiological Research Database of Spain's Public Health System Data by Vaccination Status Perspectives in health information management 21(1):1i 2024 [PMID: 40135710]

Coxiella burnetii (Q fever)

  1. Teutsch SM, Nunez CA, Morris A, Eslick GD, Elliott EJ. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2023 Communicable diseases intelligence (2018) 49 2025 [PMID: 40127698]
  2. Wambua L, Bett B, Abkallo HM, Muturi M, Nthiwa D, Nyamota R, Kiprono E, Kirwa L, Gakuya F, Bartlow AW, Middlebrook EA, Fair J, Njenga K, Gachohi J, Mwatondo A, Akoko JM. National serosurvey and risk mapping reveal widespread distribution of Coxiella burnetii in Kenya Scientific reports 15(1):9706 2025 [PMID: 40113846]

Eastern equine encephalitis virus

  1. Parashar B, Malviya R, Sridhar SB, Wadhwa T, Talath S, Shareef J. Eastern equine encephalitis virus: Pathogenesis, immune response, and clinical manifestations Infectious medicine 4(1):100167 2025 [PMID: 40026316]

Ebola virus

  1. Imani-Musimwa P, Grant E, Mukadi-Bamuleka D, Fraterne-Muhayangabo R, Kitenge-Omasumbu R, Mbala-Kingebeni P, Tsongo-Kibendelwa Z, Nyakio-Ngeleza O, Claris-Mwatsi I, Sihali-Kyolov J, Barhwamire-Kabesha T, Kavira-Malengera C, Feza-Malira M, Bitwe-Mihanda R, Sengeyi-Mushengezi-Amani D, Ververs M. Neonatal Survival Following Spontaneous Maternal Recovery From Ebola Virus Disease in a Resource-Limited Setting in Western Democratic Republic of the Congo Case reports in infectious diseases 2025:2987569 2025 [PMID: 40125488]
  2. Fallah MP, Van Ryn C, Moses JS, Badio M, Fayiah T, Johnson K, Gayedyu-Dennis D, Eghrari AO, Weiser SD, Porco TC, Martin JN, Peluso MJ, McIlwain DR, Dighero-Kemp B, Higgs E, Hensley LE, Rutherford GW, Reilly C, Kelly JD. Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control study The Lancet. Microbe :101033 2025 [PMID: 40081398]
  3. Anderer S. Sudan Virus Disease Outbreak in Uganda Spurs First-Ever Ebola Vaccine Trial JAMA 2025 [PMID: 40053339]
  4. Singh RK, Sarkar K, Das RK. In-silico repurposing of antiviral compounds against Marburg virus: a computational drug discovery approach In silico pharmacology 13(1):41 2025 [PMID: 40061630]
  5. Shcherbakov DN, Isaeva AA, Mustaev EA. Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies Antibodies (Basel, Switzerland) 14(1) 2025 [PMID: 40136471]
  6. Umulisa MM, Uwizera AU, Ezeanochie N, Noben J, Indoe EP, Kayumba M, Busasa R, Umutoni G, Mushimiyimana A, Kayitare P, Ingabire R, Sindayigaya P, Dine RD. Community members' knowledge, attitude, and practices towards Ebola virus prevention in the Western Province of Rwanda Journal of health, population, and nutrition 44(1):65 2025 [PMID: 40045430]
  7. Koul M, Kaushik S, Singh K, Sharma D. VITALdb: to select the best viroinformatics tools for a desired virus or application Briefings in bioinformatics 26(2) 2025 [PMID: 40063348]
  8. Lee YZ, Zhang YN, Newby ML, Ward G, Gomes KB, Auclair S, DesRoberts C, Allen JD, Ward AB, Stanfield RL, He L, Crispin M, Wilson IA, Zhu J. Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modification bioRxiv : the preprint server for biology 2025 [PMID: 40060701]
  9. Havens JL, Kosakovsky Pond SL, Zehr JD, Pekar JE, Parker E, Worobey M, Andersen KG, Wertheim JO. Dynamics of natural selection preceding human viral epidemics and pandemics bioRxiv : the preprint server for biology 2025 [PMID: 40060453]

Escherichia coli

  1. Ling XH, Zhang B, Ren HJ, Li MY, Liu SD, Luo MR, Guo KW, Han SC, He WR, Zhang GP, Zhang YH, Wan B. Preparation and epitope identification of a novel monoclonal antibody against 3A protein of Senecavirus A Veterinary microbiology 303:110442 2025 [PMID: 40023895]
  2. Tang Z, Feng D, Fan W, Yan L, Song S. Generation of an artificially attenuated fowl adenovirus 4 viral vector using the reverse genetics system based on full-length infectious clone Veterinary research 56(1):62 2025 [PMID: 40119416]
  3. Felice AG, Rodrigues TCV, Marques PH, Zen FL, Lemes MR, Trevisan RO, Andrade BS, de Oliveira CJF, Azevedo VAC, Tiwari S, Soares SC. In silico construction of a multi-epitope vaccine (RGME-VAC/ATS-1) against the Rickettsia genus using immunoinformatics Memorias do Instituto Oswaldo Cruz 120:e240201 2025 [PMID: 40136144]
  4. Adepoju OA, Quinnell D, Sirohi H, Amlabu E, Sallau AB, Ibrahim A, Atawodi SE, Shuaibu MN, Chang G, Balogun EO. Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A(2) Engineering in life sciences 25(3):e70005 2025 [PMID: 40124852]
  5. Agbenyega T, Schuind AE, Adjei S, Antony K, Aponte JJ, Buabeng PBY, Clemens JD, Hossain L, Kemp TJ, Mercer LD, Pinto LA, Qadri F, Sukraw K, Bhat N, Zaman K. Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial The Lancet. Infectious diseases 2025 [PMID: 40120597]
  6. Nakao R, Yamaguchi T, Shibasaki H, Saeki J, Takahashi A, Tominaga R, Abe K, Akeda Y, Nakagawa-Nakamura T, Nishino T, Ishihara K, Jinno-Oue A, Inoue S. Assessment of periodontitis vaccine using three different bacterial outer membrane vesicles in canine model mSphere :e0103324 2025 [PMID: 40099899]
  7. Chen H, Wang X, Ge H, Geng S, Liu L, Fang B, Ren L. RmZHD Surface-Displayed Escherichia coli for High Efficiency and Low-Cost Degradation of Zearalenone ACS applied bio materials 2025 [PMID: 40080174]
  8. Sudaraka Tennakoon MSBWTMN, Lee KH, Shin HJ. Expression of recombinant swine ferritin heavy chain with enhanced solubility in Escherichia coli and simplified purification of ferritin nanoparticles Protein expression and purification 231:106700 2025 [PMID: 40086537]
  9. Halder S, Jaiswal N, Balajee SC, Mahata N. Efficient production of a novel recombinant fusion protein of EIEC effector IpaD and EGFP: Biophysical characterization and functional studies Biochimica et biophysica acta. Proteins and proteomics 1873(4):141066 2025 [PMID: 40086498]
  10. Zhang C, Li S, Upadhyay I, Vakamalla SSR, Lauder KL, Hansen C, Massey KA, Hayes C, Herndon NL, Zhang W. Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic Escherichia coli post-weaning diarrhea Infection and immunity :e0040624 2025 [PMID: 40071919]
  11. Davies HG, Kyohere M, Tusubira V, Amone A, Wamawobe A, Komugisha C, Musoke P, Hookham L, Ravji P, Etti M, Nsimire Sendagala J, Shelley DR, Farley C, Voysey M, Spiller OB, Peacock J, Sekikubo M, Heath PT, Le Doare K. Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants Open forum infectious diseases 11(Suppl 3):S157-S164 2024 [PMID: 40070704]
  12. Atuhaire P, Kyohere M, Tusubira V, Davies HG, Musoke P, Sekikubo M, Wamawobe A, Peacock J, Le Doare K. HIV Exposure and Neonatal Sepsis: A Descriptive Etiological Study Open forum infectious diseases 11(Suppl 3):S187-S192 2024 [PMID: 40070699]
  13. Hookham L, Tusubira V, Wamawobe A, Shelley DR, Farley C, Portal EAR, Beach S, Davies HG, Karampatsas K, Kyohere M, Peacock J, Musoke P, Spiller OB, Heath PT, Sekikubo M, Le Doare K. Infectious Causes of Stillbirths: A Descriptive Etiological Study in Uganda Open forum infectious diseases 11(Suppl 3):S165-S172 2024 [PMID: 40070697]
  14. Khan MS, Shakya M, Verma CK. Computational modelling of a multiepitope vaccine targeting glycoprotein-D for herpes simplex virus 2 (HSV-2): an immunoinformatic analysis Molecular diversity 2025 [PMID: 40057939]
  15. Chandpa HH, Naskar S, Meena J. Computer Integrated Dominant Epitopes Evoke Protective Immune Response Against Streptococcus pneumoniae Immunology 2025 [PMID: 40056072]
  16. Ou X, Liu E, Rashid F, Pei S, Zhang G, Anthony R, Xing R, Huang F, Xia H, Zheng Y, Song Y, Zhou Y, Zhao B, Wang S, Lin M, Zhou L, Zhao Y. Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing Frontiers in immunology 16:1498448 2025 [PMID: 40124357]
  17. Zaher MR, El-Husseiny MH, Hagag NM, El-Amir AM, El Zowalaty ME, Tammam RH. A novel immunoinformatic approach for design and evaluation of heptavalent multiepitope foot-and-mouth disease virus vaccine BMC veterinary research 21(1):152 2025 [PMID: 40055785]
  18. Shirmohammadpour M, Mehrasbi MR, Noshiranzadeh N, Afshar D, Mansori K, Mirzaei B. Investigation of the effect of anti-PIA/PNAG antibodies on biofilm formation in Escherichia coli Frontiers in microbiology 16:1552670 2025 [PMID: 40115191]
  19. Blizard GS, Dwivedi G, Pan YG, Hou C, Etersque JM, Said H, Chevrier A, Lavertu M, Ni H, Davis B, Tam Y, Cao Q, Mach RH, Weissman D, Alameh MG, Sellmyer MA. Monitoring mRNA vaccine antigen expression in vivo using PET/CT Nature communications 16(1):2234 2025 [PMID: 40044669]
  20. Noori Goodarzi N, Barzi SM, Ajdary S, Chiani M, Yekaninejad MS, Badmasti F, Pourmand MR. Immunogenic evaluation of LptD + LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae Journal of translational medicine 23(1):261 2025 [PMID: 40038701]
  21. Yamamoto LS, Trentini MM, Rodriguez D, Silveira PHS, Januzzi AD, Carvalho ACO, Leite LCC, Kanno AI. Exploring BCG to deliver avidin fusion antigens from Schistosoma mansoni Memorias do Instituto Oswaldo Cruz 120:e240167 2025 [PMID: 40053008]
  22. Rahman M, Jahan F, Hanif S, Yeamin A, Shoab AK, Andrews JR, Lu Y, Billington S, Pilotte N, Shanta IS, Jubair M, Rahman M, Kabir M, Haque R, Tofail F, Hossain MS, Mahmud ZH, Ercumen A, Benjamin-Chung J. Effects of household concrete floors on maternal and child health: the CRADLE trial - a randomised controlled trial protocol BMJ open 15(3):e090703 2025 [PMID: 40032381]
  23. Khosravi V, Mahdavi AH, Hatamzade Esfahani N. Effects of Zataria multiflora, Salvia officinalis and Probiotics on Intestinal Microbial Colonization, Immunocompetence, Jejunal Histology and Performance of Laying Hens Veterinary medicine and science 11(2):e70147 2025 [PMID: 40132055]
  24. Jia X, Hu S, Kuang X, Qiao Y. Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18-45 years: A 9-year follow-up study Infectious medicine 4(1):100164 2025 [PMID: 40083805]
  25. Celebi O, Baser S, Guler MC, Taghizadehghalehjoughi A, Rakici E, Aydin E, Celebi D. Molecular characterization of resistance and biofilm genes of ESKAPE pathogens isolated from clinical samples: examination of the effect of boric acid on biofilm ability by cell culture method BMC microbiology 25(1):106 2025 [PMID: 40025436]
  26. Ranjbar KJ, Sarkoohi P, Shahbazi B, Babaei M, Ahmadi K. Bioinformatics analysis of the in silico engineered protein vaccine with and without Escherichia coli heat labile enterotoxin adjuvant on the model of Klebsiella pneumoniae Scientific reports 15(1):7321 2025 [PMID: 40025224]
  27. Su J, Zhang J, Feng X, Liu J, Gao S, Liu X, Yang M, Chen Z. A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development Molecular therapy : the journal of the American Society of Gene Therapy 2025 [PMID: 40022448]
  28. Abbas H, Best N, Zerna G, Beddoe T. Development of LAMP assay for early detection of Yersinia ruckeri in aquaculture PeerJ 13:e19015 2025 [PMID: 40028206]
  29. Khazaei S, Dalimi A, Pirestani M, Ghafarifar F. Designing and Evaluation of a Plasmid Encoding Immunogenic Epitopes From Echinococcus granulosus Eg95-1-6, P29, and GST Against Hydatid Cyst in BALB/c Mice Journal of parasitology research 2025:1655679 2025 [PMID: 40041800]
  30. López-Siles M, Tajuelo A, Caravaca-Fuentes P, Planas M, Feliu L, McConnell MJ. Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria Current research in microbial sciences 8:100363 2025 [PMID: 40084383]

Hantavirus

  1. Ying Q, Zhang X, Gu T, Zhang J, Dong Y, Feng W, Li D, Wu X, Wang F. Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein Antiviral research 237:106124 2025 [PMID: 40020878]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Gebrehiwot GT, Tilahun M, Gebrehiwot H, Kahsay H, Gebregziabher G, Haddis S, Tesfay M, Alemseged G, Alemseged G, Kalayu M, Yisfa G, Alemu M, Bidre HB, Teklue T. Prevalence and determinants of child immunization coverage in Ethiopia: Evidence from the 2019 mini-demographic and health survey Human vaccines & immunotherapeutics 21(1):2478707 2025 [PMID: 40103405]
  2. Yap DYH, Chan GCK, Ho S, Wong RSM, Chan SL, Lee VHF, Lam W, Li PH. Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong Human vaccines & immunotherapeutics 21(1):2463185 2025 [PMID: 40063340]
  3. Dale R, He H, Chen Y. Absorbing Markov chain model of PrEP drug adherence to estimate adherence decay rate and probability distribution in clinical trials Journal of theoretical biology 604:112086 2025 [PMID: 40086122]
  4. Tian Y, Huang W, Yang J, Wen Z, Geng Y, Zhao C, Zhang H, Wang Y. Corrigendum to "Systematic identification of HEV ORF2 interactome reveals that TMEM134 engages in ORF2-mediated NF-κB pathway" [Virus Research 228 (2017) 102-108] Virus research 354:199553 2025 [PMID: 40058986]
  5. Benlarbi M, Kenfack DD, Dionne K, Côté-Chenette M, Beaudoin-Bussières G, Bélanger É, Ding S, Goni OH, Ngoume YF, Tauzin A, Medjahed H, Ghedin E, Duerr R, Finzi A, Tongo M. Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon Virology 605:110467 2025 [PMID: 40037139]
  6. MacLean F, Tsegaye AT, Graham JB, Swarts JL, Vick SC, Potchen NB, Cruz Talavera I, Warrier L, Dubrulle J, Schroeder LK, Saito A, Mar C, Thomas KK, Mack M, Sabo MC, Chohan BH, Ngure K, Mugo NR, Lingappa JR, Lund JM. Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract The Journal of clinical investigation 2025 [PMID: 40131862]
  7. Teutsch SM, Nunez CA, Morris A, Eslick GD, Elliott EJ. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2023 Communicable diseases intelligence (2018) 49 2025 [PMID: 40127698]
  8. Foo IJH, Kedzierski L, Kedzierska K. Immune responses underpinning acute co-infections with unrelated viruses: timing and location matter International immunology 2025 [PMID: 40127041]
  9. Hu J, Jia Z, Wang M, Nie L, Fu W, Zhang Q, Qin H, Nie J, Xu X, Xu L, Wang F, Chen Y, Xing B, Li T, Li D, Li S, Xia N, Wang X, Huang W. Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests NPJ vaccines 10(1):55 2025 [PMID: 40118915]
  10. Bixler BJ, Royer CJ, Petit Iii RA, Moller AG, Sefton S, Thomas S, Tunali A, Collins LF, Farley MM, Satola SW, Read TD. Comparative genomic analysis of emerging non-typeable Haemophilus influenzae (NTHi) causing emerging septic arthritis in Atlanta PeerJ 13:e19081 2025 [PMID: 40130174]
  11. Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Ritz J, Gibbs M, Kouekam HT, Esser MT, Daar ES, Choudhary M, Deo R, Fletcher CV, Li JZ, Hughes MD, Smith D, Wohl DA. Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies iScience 28(3):111938 2025 [PMID: 40124489]
  12. Zubair A, Al-Emam A, Ali M, Hussain SM, Elmagzoub RM. Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the Asia PloS one 20(3):e0317382 2025 [PMID: 40117271]
  13. Portillo-Romero AJ, Carnalla M, Allen-Leigh B, Esquivel-Ocampo EA, Lazcano-Ponce E. Educational Needs for Preventing and Managing Human Papillomavirus-Related Diseases in Men Living with HIV in Mexico Journal of cancer education : the official journal of the American Association for Cancer Education 2025 [PMID: 40116989]
  14. Trifone C, Richard C, Pagliuzza A, Dufour C, Lemieux A, Clark NM, Janaka SK, Fennessey CM, Keele BE, Fromentin R, Estes JD, Kaufmann DE, Finzi A, Evans DT, Chomont N. Contribution of intact viral genomes persisting in blood and tissues during ART to plasma viral rebound in SHIV-infected rhesus macaques iScience 28(3):111998 2025 [PMID: 40104070]
  15. Saleem Z, Mekonnen BA, Orubu ES, Islam MA, Nguyen TTP, Ubaka CM, Buma D, Thuy NDT, Sant Y, Sono TM, Bochenek T, Kalungia AC, Abdullah S, Miljković N, Yeika E, Niba LL, Akafity G, Sefah IA, Opanga SA, Kitutu FE, Khuluza F, Zaranyika T, Parajuli A, Darweesh O, Islam S, Kumar S, Nabayiga H, Jairoun AA, Chigome A, Ogunleye O, Fadare J, Massele A, Cook A, Jelić AG, Godói IPD, Phillip A, Meyer JC, Funiciello E, Lorenzetti G, Kurdi A, Haseeb A, Moore CE, Campbell SM, Godman B, Sharland M. Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications Expert review of anti-infective therapy 2025 [PMID: 40110804]
  16. Ngoufack Jagni Semengue E, Takou D, Potesta M, Ndjeyep Djupsa SC, Montesano C, Chenwi CA, Beloumou G, Nka AD, Kengni Ngueko AM, Molimbou E, Etame NK, Gouissi Anguechia DH, Mundo Nayang AR, Tueguem PP, Ndomgue T, Tambe Ayuk Ngwese D, Moko Fotso LG, Tommo Tchouaket CM, Ka'e AC, Fainguem N, Abega Abega CA, Mandeng N, Epee E, Esso L, Etoundi Mballa G, Santoro MM, Z-K Bissek AC, Otokoye Otshudiema J, Alteri C, Boum Ii Y, Marcelin AG, Ceccherini-Silberstein F, Ndjolo A, Perno CF, Kaseya J, Colizzi V, Ndembi N, Fokam J. Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak response PLOS global public health 5(3):e0004312 2025 [PMID: 40106487]
  17. Alba C, Malhotra S, Horsfall S, Barnhart ME, Bekker A, Chapman K, Cunningham CK, Fast PE, Fouda GG, Freedberg KA, Goga A, Ghazaryan LR, Leroy V, Mann C, McCluskey MM, McFarland EJ, Muturi-Kioi V, Permar SR, Shapiro R, Sok D, Stranix-Chibanda L, Weinstein MC, Ciaranello AL, Dugdale CM. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens PloS one 20(3):e0318940 2025 [PMID: 40106399]
  18. Hillus D, Le NH, Tober-Lau P, Fietz AK, Hoffmann C, Stegherr R, Huang L, Baumgarten A, Voit F, Bickel M, Goldstein G, Wyen C, Stocker H, Wünsche T, Lee M, Schulbin H, Vallée M, Bohr U, Potthoff A, Cordes C, Isner C, Knox B, Carmona A, Stobäus N, Balicer R, Kurth F, Sander LE. Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study The Lancet. Infectious diseases 2025 [PMID: 40118087]
  19. Tameris M, Rozot V, Imbratta C, Geldenhuys H, Mendelsohn SC, Kany Luabeya AK, Shenje J, Tredoux N, Fisher M, Mulenga H, Bilek N, Young C, Veldsman A, Botes N, Thole J, Fritzell B, Mukherjee R, Jelsbak IM, Rodriguez E, Puentes E, Doce J, Marinova D, Gonzalo-Asensio J, Aguilo N, Martin C, Scriba TJ, Hatherill M. Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting EBioMedicine 114:105628 2025 [PMID: 40101388]
  20. MacGibbon J, Storer D, Bavinton BR, Cornelisse VJ, Broady TR, Chan C, Smith AKJ, Rule J, Mao L, Holt M. Mpox vaccination coverage among Australian gay and bisexual men and non-binary people: Results of behavioural surveillance in early 2024 Vaccine 55:127014 2025 [PMID: 40101325]
  21. Gurgo C, Fenizia C, McKinnon K, Hsia RC, Franchini G. Expression of HIV from a 1-LTR circular DNA in the absence of integration Retrovirology 22(1):2 2025 [PMID: 40098202]
  22. Richardson SJ, Rodriguez-Calvo T, Laiho JE, Kaddis JS, Nyalwidhe JO, Kusmartseva I, Morfopoulou S, Petrosino JF, Plagnol V, Maedler K, Morris MA, Nadler JL, Atkinson MA, von Herrath M, Lloyd RE, Hyoty H, Morgan NG, Pugliese A. Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue Diabetologia 2025 [PMID: 40090994]
  23. Chen W, Fan Q, Cheng W, Zhang J, He L, Jiang J, Liu X, Zhu X, Xing H, Feng Y, Zhong P, Pan X, Chai C. Phylogenetic analysis and transmission networks highlight the role of older adults in the transmission of HIV-1 in northern Zhejiang, China Virology journal 22(1):75 2025 [PMID: 40089756]
  24. Spencer JC, Yanguela J, Spees LP, Odebunmi OO, Ilyasova AA, Biddell CB, Hassmiller Lich K, Mills SD, Higgins CR, Ozawa S, Wheeler SB. Methodological Approaches for Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review Medical decision making : an international journal of the Society for Medical Decision Making :272989X251325509 2025 [PMID: 40088125]
  25. . Tenofovir 2006 [PMID: 30000609]
  26. . Emtricitabine 2006 [PMID: 30000608]
  27. Watts V, Usdin M, Mearkle R, Sriskandan S, Cordery R, Millership S, Saliba V, Edmundson C, Pai A, Brown CS, Balasegaram S, Lamagni T, Decraene V. Antibiotic chemoprophylaxis for close contacts of invasive group A streptococcus in community settings: Evidence review The Journal of infection 90(4):106468 2025 [PMID: 40089213]
  28. Lefèvre L, Quenard F, Cabras O, Medo E, Barry TA, Cabié A, Cuzin L. Vaccination coverage against three viral sexually transmitted diseases, among 18-to-30-year-olds seen between May 2023 and May 2024 in the Martinique University Hospital CeGIDD Infectious diseases now 55(3):105055 2025 [PMID: 40089154]
  29. Lucey M, Burns F, Bhagani S, Lipman M, Madge S, Johnson M, Hart J, Smith C, Peppa D, Barber TJ. SARS-CoV-2 antibody prevalence in adults living with HIV AIDS (London, England) 2025 [PMID: 40080115]
  30. Vincent JP, Ségéral O, Kania D, Borand L, Adoukara JP, Pivert A, Koné A, Tiendrebeogo ASE, Tall H, Schaeffer L, Vray M, Sanou AM, Njouom R, Cloherty G, Hashimoto N, Miura T, Sugiura W, Sovann S, Yang JS, Delvallez G, Lunel-Fabiani F, Tanaka Y, Shimakawa Y. Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study The lancet. Gastroenterology & hepatology 2025 [PMID: 40090346]
  31. Songtaweesin WN, Puthanakit T. Long-acting PrEP for adolescent girls and young women The lancet. HIV 2025 [PMID: 40088910]
  32. Monti EB, Penichet D, Rudd M, Yoong D, Pathan SS, Moin A, Myers SA, Tan DH. Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review International journal of STD & AIDS :9564624251325312 2025 [PMID: 40072487]
  33. Langat R, Burns N, Daud I, Kibuuka H, Owuoth J, Sing'oei V, Maswai J, Parker Z, Tiamiyu A, Bahemana E, Gervas R, Dear NF, Frndak S, Parikh AP, Duff ER, Imbach M, Omar B, Hern J, Shah N, Ake JA, Crowell TA, Romo ML. The vast majority of SARS-CoV-2 infections were asymptomatic in a clinic-based cohort of people with and without HIV in four African countries BMC infectious diseases 25(1):345 2025 [PMID: 40069614]
  34. Uusküla A, Tisler A, DeHovitz J, Murenzi G, Castle PE, Clifford G. Prevention and control of HPV-related cancers in people living with HIV The lancet. HIV 2025 [PMID: 40086453]
  35. Clay PA, Pollock ED, Saldarriaga EM, Pathela P, Macaraig M, Zucker JR, Crouch B, Kracalik I, Spicknall IH. Modeling the Impact of Vaccine Dose Prioritization Strategies During the 2022 Mpox Outbreak American journal of epidemiology 2025 [PMID: 40069944]
  36. Sivanandham S, Sivanandham R, Xu C, Symmonds J, Sette P, He T, Funderburg N, Abdel-Mohsen M, Landay A, Apetrei C, Pandrea I. Plasma lipidomic alterations during pathogenic SIV infection with and without antiretroviral therapy Frontiers in immunology 16:1475160 2025 [PMID: 40129985]
  37. Atuhaire P, Kyohere M, Tusubira V, Davies HG, Musoke P, Sekikubo M, Wamawobe A, Peacock J, Le Doare K. HIV Exposure and Neonatal Sepsis: A Descriptive Etiological Study Open forum infectious diseases 11(Suppl 3):S187-S192 2024 [PMID: 40070699]
  38. Carlander C, Borgfeldt C, Hammarstedt Nordenvall L. [Catch-up vaccination prevents HPV infection and related precancers when given up to age 26] Lakartidningen 122 2025 [PMID: 40070302]
  39. Ha NY, Kim AR, Jeong H, Cheon S, Park CR, Choe JH, Kim HJ, Yoon JW, Kim M, An MY, Jung S, Do HN, Lee J, Kim YS. Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count Journal of Korean medical science 40(9):e28 2025 [PMID: 40065712]
  40. Kgoadi K, Bajpai P, Ibegbu CC, Dkhar HK, Enriquez AB, Dawa S, Cribbs SK, Rengarajan J. Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection Nature communications 16(1):2397 2025 [PMID: 40064940]
  41. Moon Z, Campbell L, Ottaway Z, Fox J, Burns F, Hamzah L, Ustianowski A, Clarke A, Schoeman S, Sally D, Tariq S, Post FA, Horne R. Mapping Vaccination Mindsets among UK Residents of Black Ethnicities with HIV: Lessons from COVID-19 AIDS and behavior 2025 [PMID: 40063203]
  42. Kabarambi A, Kizito S, Hunleth J, Silver MI, Niyonzima N, Ssewamala F. HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women Living with HIV-in Central Uganda AIDS and behavior 2025 [PMID: 40063202]
  43. Garcia-Knight MA, Kelly JD, Lu S, Tassetto M, Goldberg SA, Zhang A, Pineda-Ramirez J, Anglin K, Davidson MC, Chen JY, Fortes-Cobby M, Park S, Martinez A, So M, Donovan A, Viswanathan B, Richardson ET, McIlwain DR, Gaudilliere B, Rutishauser RL, Chenna A, Petropoulos C, Wrin T, Deeks SG, Abedi GR, Saydah S, Martin JN, Briggs Hagen M, Midgley CM, Peluso MJ, Andino R. Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections JCI insight 10(5) 2025 [PMID: 40059831]
  44. Velaphi S, Madewell ZJ, Tippett-Barr B, Blau DM, Rogena EA, Lala SG, Mahtab S, Swart PJ, Akelo V, Onyango D, Otieno K, Rogena EA, Were JA, Bassat Q, Carrilho C, Mandomando I, Torres-Fernandez D, Varo R, Luke R, Moses F, Nwajiobi-Princewill P, Ogbuanu IU, Ojulong J, El Arifeen S, Gurley ES, Assefa N, Gedefa L, Madrid L, Scott JAG, Wale H, Juma J, Keita AM, Kotloff KL, Sow SO, Tapia MD, Mutevedzi P, Whitney CG, Madhi SA. Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 40059623]
  45. Salvo PF, Lombardi F, Sanfilippo A, Iannone V, Baldin G, Borghetti A, Torti C, Di Giambenedetto S. Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak Travel medicine and infectious disease 65:102832 2025 [PMID: 40068726]
  46. Sossen B, Kubjane M, Meintjes G. Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107876 2025 [PMID: 40064284]
  47. Yappalparvi A, Khatib MN, Balaraman AK, Rekha MM, Kaur M, Sharma GC, Sudan P, Naidu KS, Singh R, Ramashankar S, Khati K, Chauhan SS, Verma L, Sidhu A, Mehta R, Sah R, Gaidhane AM, Shabil M, Chipeta JC, Bushi G. Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis AIDS research and therapy 22(1):31 2025 [PMID: 40057788]
  48. Kimera A, Rujumba J, Ndikuno CK, Ndeezi G, Mukiza N, Basenero A, Piloya T, Bakeera-Kitaka S, Nabulya R, Nalumansi AM, Namagembe A, Bagala I, Namutosi A, Kobel E, Bazaali Z, Nansubuga C, Kinera I, Sekina H, Kitonsa JP, Kule I, Musiime V. Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital BMC pediatrics 25(1):175 2025 [PMID: 40057675]
  49. Trajman A, Campbell JR, Kunor T, Ruslami R, Amanullah F, Behr MA, Menzies D. Tuberculosis Lancet (London, England) 405(10481):850-866 2025 [PMID: 40057344]
  50. Oyebanji OA, Yin A, Sundheimer N, Ragavapuram V, Shea P, Cao Y, Chan PA, Nanda A, Tyagi R, Raza S, Mujahid N, Abul Y, Balazs AB, Bosch J, King CL, Klein SL, Gravenstein S, Canaday DH, Wilson BM. COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents Aging clinical and experimental research 37(1):73 2025 [PMID: 40055264]
  51. Skalland TM, de Dieu Tapsoba J, Zangeneh SZ, Floyd S, Ayles H, Bock P, Fidler S, Eshleman SH, Hayes RJ, Donnell D. A survey weighted analysis of HPTN 071 (PopART) primary outcome of HIV incidence AIDS research and therapy 22(1):30 2025 [PMID: 40055795]
  52. Kerst A, Gerlich M. [Barriers to vaccination - parents' attitudes towards HPV vaccination] Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2025 [PMID: 40053095]
  53. Day S, Carter A, Lloyd A, Seña AC, Radolf JD, Tucker JD. Barriers and Facilitators of Participation in Syphilis Vaccine Trials: A Qualitative Analysis to Inform Trial Design and Community Engagement in the United States Sexual and reproductive health matters :1-26 2025 [PMID: 40052273]
  54. Alsoubani M, Chow J. Navigating Coronavirus Disease 2019 in Immunocompromised Populations: Evolving Risk Factors, Treatment, and Outcomes Infectious disease clinics of North America 2025 [PMID: 40055107]
  55. Das C, Kundu CN. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects Critical reviews in microbiology :1-24 2025 [PMID: 40051042]
  56. Bertrand L, Nelde A, Ramirez BC, Hatin I, Arbes H, François P, Demais S, Labaronne E, Decimo D, Guiguettaz L, Grégoire S, Bet A, Beauclair G, Gross A, Ziegler MC, Pereira M, Jeger-Madiot R, Verdier Y, Vinh J, Cardinaud S, Graff-Dubois S, Esclatine A, Gouttefangeas C, Altfeld M, Hocqueloux L, Samri A, Autran B, Lambotte O, Rammensee HG, Ricci EP, Walz J, Namy O, Moris A. Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling Nature communications 16(1):2243 2025 [PMID: 40050281]
  57. de Jong HK, Grobusch MP. Zika virus: an overview update Current opinion in HIV and AIDS 2025 [PMID: 40048580]
  58. Okita G, Suenaga K, Sakaguchi M, Murakami T. A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells PloS one 20(3):e0312205 2025 [PMID: 40048445]
  59. Borges ÁH, Russell M, Tait D, Scriba TJ, Nemes E, Skallerup P, van Brakel E, Cabibbe AM, Cirillo DM, Leuvennink-Steyn M, Rutkowski KT, Wood GK, Thierry-Carstensen B, Tingskov PN, Meldgaard EC, Kristiansen MP, Søndergaard RE, Hansen CH, Follmann F, Jensen CG, Gela A, Ntinginya NE, Ruhwald M, Shenje J, White L, Innes C, Selepe P, Ngaraguza B, Holmgren C, Collings T, Andersen P, Dawson R, Churchyard G, Sabi I, Diacon AH, Mortensen R, Hatherill M. Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial The Lancet. Infectious diseases 2025 [PMID: 40056922]
  60. Chesson HW, Markowitz LE. Strong Herd Effects of Human Papillomavirus Vaccination The Journal of infectious diseases 2025 [PMID: 40042854]
  61. Tisoncik-Go J, Lewis TB, Whitmore LS, Voss K, Niemeyer S, Dai J, Kim P, Hubbell K, Iwayama N, Ahrens C, Wangari S, Murnane R, Edlefsen PT, Guerriero KA, Gale M Jr, Fuller DH, O'Connor MA. Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques Frontiers in immunology 16:1535807 2025 [PMID: 40103823]
  62. Koul M, Kaushik S, Singh K, Sharma D. VITALdb: to select the best viroinformatics tools for a desired virus or application Briefings in bioinformatics 26(2) 2025 [PMID: 40063348]
  63. Xu P, Yuan D, Moog C, Su B. Efforts toward achieving the goal of ending AIDS by 2030: from antiretroviral drugs to HIV vaccine and cure research Science China. Life sciences 2025 [PMID: 40048070]
  64. Bailón L, Moltó J, Curran A, Cadiñanos J, Carlos Lopez Bernaldo de Quirós J, de Los Santos I, Ambrosioni J, Imaz A, Benet S, Suanzes P, Navarro J, González-García J, Busca C, Pérez-Latorre L, Berenguer J, García-Fraile LJ, Mejía-Abril G, Miró JM, Scévola S, Moreno S, Domingo P, Tian Y, Frankot M, Lim D, Cai Y, Vendrame E, Guo S, Wallin JJ, Geleziunas R, SenGupta D, Alarcón-Soto Y, Leal I, Aranguen A, Garcia-Garcia M, McGowan I, Brander C, Arribas JR, Mothe B. Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial Nature communications 16(1):2146 2025 [PMID: 40038256]
  65. Ramezani-Rad P, Marina-Zárate E, Maiorino L, Myers A, Kaczmarek Michaels K, Pires IS, Bloom NI, Melo MB, Lemnios AA, Lopez PG, Cottrell CA, Burton I, Groschel B, Pradhan A, Stiegler G, Budai M, Kumar D, Pallerla S, Sayeed E, Sagar SL, Kasturi SP, Van Rompay KK, Hangartner L, Wagner A, Burton DR, Schief WR, Crotty S, Irvine DJ. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in non-human primates The Journal of clinical investigation 2025 [PMID: 40036068]
  66. Johnson MJ, Lazarus SK, Bennett AE, Tovar-Salazar A, Robertson CE, Kofonow JM, Li S, McCollister B, Nunes MC, Madhi SA, Frank DN, Weinberg A. Gut microbiota and other factors associated with increased T cell regulation in HIV-exposed uninfected infants Frontiers in immunology 16:1533003 2025 [PMID: 40098966]
  67. Brites C, Tonto PB, Vallinoto AC, Dos Santos Oliveira O, Simionatto S, Bay M, Reuter T, Gomes-da-Silva MM, Medeiros M, Mayoral R, Luz E, Rocha M, Vechi H, Herrera BB. Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil Frontiers in public health 13:1511374 2025 [PMID: 40098798]
  68. Fan C, Wu X, Liu Q, Li Q, Liu S, Lu J, Yang Y, Cao Y, Huang W, Liang C, Ying T, Jiang S, Wang Y. Correction: Fan et al. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. Viruses 2018, 10, 448 Viruses 17(3) 2025 [PMID: 40091792]
  69. Soleimani M, Jalilvand A. Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness Scientific reports 15(1):7450 2025 [PMID: 40032988]
  70. Garrett C, N'Diaye A, Qiao S, Li X. "I'm Afraid to Put Any More of It Into My Body": COVID-19 Vaccination and Booster Barriers and Facilitators Among People with HIV in South Carolina AIDS and behavior 2025 [PMID: 40029581]
  71. Burbach SM, Briney B. A curriculum learning approach to training antibody language models bioRxiv : the preprint server for biology 2025 [PMID: 40060663]
  72. Wongsethanatada A, Songtaweesin WN, Wongharn P, Moonwong J, Khamthi S, Pitikawinwong L, Puthanakit T. Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults AIDS research and therapy 22(1):28 2025 [PMID: 40025583]
  73. Vieira Alves M, Oliveira Pereira G, Alves Dos Santos Silva L, Dória Araújo E, Barreto da Silva BE, Dolce de Lemos LM, de Aragão Batista MV. Intratype variants and high genotypic diversity of human papillomavirus with polymorphisms in the antigenic hypervariable loops of the L1 protein from women living with human immunodeficiency virus in Northeastern Brazil Journal of medical microbiology 74(3) 2025 [PMID: 40105445]
  74. Liu S, Liu P, Lu Q, Shen Y, Zhang L, Liang Z, Yu Y, Huang W, Wang Y. The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS-CoV-2 Omicron Variants Journal of medical virology 97(3):e70242 2025 [PMID: 40062404]
  75. Romanov A, Knappe GA, Ronsard L, Suh H, Omer M, Chapman AP, Lewis VR, Spivakovsky K, Canales J, Reizis B, Tingle RD, Cottrell CA, Schiffner T, Lingwood D, Bathe M, Irvine DJ. DNA origami vaccines program antigen-focused germinal centers bioRxiv : the preprint server for biology 2025 [PMID: 40060683]
  76. Ochieng E, Robinson V, Anderson E, Niles-Carnes L, Smith BL, Armstrong WS, Lora M, Colasanti JA, Collins LF. Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South Open forum infectious diseases 12(3):ofaf096 2025 [PMID: 40046888]
  77. Onyando BO, Nyawanda BO, Onguru D, Haidara FC, Okello C, Anyango RO, Orege IK, Ogolla S, Ogwel B, Awuor AO, Kadivane S, Ngere P, Nasimiyu C, Osoro E, Njenga MK, Akelo V, Otedo A, Lidechi S, Ochieng JB, Otieno NA, Muok EMO, Sergon K, Worwui AK, Weldegebriel GG, Bergeri I, Sandra C, Gurry C, Nuorti JP, Amoth P, Jalang'o R, Mwenda JM, Omore R, Sow SO. Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023 Vaccine :126910 2025 [PMID: 40024835]
  78. Riches N, Henrion MYR, MacPherson P, Hahn C, Kachala R, Mitchell T, Murray D, Mzumara W, Nkoka O, Price AJ, Riches J, Seery A, Thom N, Loarec A, Lemoine M, Ndow G, Shimakawa Y, Thompson P, Morgan C, Desai S, Easterbrook P, Stockdale AJ. Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis The Lancet. Global health 13(3):e447-e458 2025 [PMID: 40021303]
  79. Bolhassani A. Editorial: The global phenotypic diversity of HIV-1: implications for pathogenesis, vaccine, and cure Frontiers in immunology 16:1572732 2025 [PMID: 40093004]
  80. Carter CA. High Risk, High Reward: By Selecting Tsg101, A Protein That Sorts The Trash, As Our Personal ESCRT, Both HIV And I Were Able To Bud Journal of molecular biology :169053 2025 [PMID: 40024433]
  81. Gutiérrez Rodríguez MA, Rodríguez Luque C, Sánchez Gómez A, Lasheras Carbajo MD, Cañellas Llabrés S, Lopez Centeno B, Morales Irala D, Vázquez Torres MC, Molina Olivas M. Factors associated with vaccination against mpox in people under preexposure prophylaxis against HIV in the Community of Madrid Enfermedades infecciosas y microbiologia clinica (English ed.) 2025 [PMID: 40023676]
  82. Stetsenko V, Gail DP, Reba S, Suzart VG, Sandhu AK, Sette A, Dezfulian MH, Arlehamn CSL, Carpenter SM. Human memory CD4(+) T-cells recognize Mycobacterium tuberculosis-infected macrophages amid broader pathogen-specific responses bioRxiv : the preprint server for biology 2025 [PMID: 40060660]
  83. Bernard OA, Arthur SE, Aminu M, Bonney EY, Abdul-Azeez AA, Chofong GN, Kafintu-Kwashie A, Sabeta CT, Yassin AA, Adiku TA. Advancing the frontiers of virology in Africa: The African Virologists Network's Mission and Progress Virology :110469 2025 [PMID: 40058992]
  84. von Elling-Tammen MS, Taft F, Thom V, Stitz J, Barbe S, Krause A. Optimizing nuclease treatment to enhance anion exchange chromatography of HIV-derived virus-like particles Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 1256:124539 2025 [PMID: 40056795]
  85. Itaki M, Endo M, Asakura H, Nagashima M, Somura Y, Takahashi A, Kayebeta A, Takahashi I, Yahata Y. Hepatitis A outbreak among men who have sex with men, Shinjuku, Japan, 2018 Western Pacific surveillance and response journal : WPSAR 16(1):1-10 2025 [PMID: 40129598]
  86. Wang X, Yang X, Zhang X, Yan H, Jin J, Ma Z, Duan J, Zhang G, Huang T, Li Y, Wu H, Zhang T, Zhu A, Jin C, Song X, Su B. Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine Frontiers in immunology 16:1554409 2025 [PMID: 40070834]
  87. Rappaport AR, Bekerman E, Boucher GR, Sung J, Carr B, Corzo CA, Larson H, Kachura MA, Scallan CD, Geleziunas R, SenGupta D, Jooss K. Differential shaping of T cell responses elicited by heterologous ChAd68/self-amplifying mRNA SIV vaccine in macaques in combination with αCTLA4, αPD-1, or FLT3R agonist Journal of immunology (Baltimore, Md. : 1950) 2025 [PMID: 40073084]
  88. Baroncelli S, Galluzzo CM, Orlando S, Luhanga R, Mphwere R, Kavalo T, Amici R, Floridia M, Andreotti M, Ciccacci F, Marazzi MC, Giuliano M. Low levels of pertussis- and measles-specific IgG antibodies in 6-week-old HIV-exposed and -unexposed Malawian infants: implications for vaccination strategies and role of long term HIV therapy Journal of tropical pediatrics 71(2) 2025 [PMID: 40064194]
  89. Mekonnen C, Abebe M, Mosisa W. A retrospective cohort studying about time to recovery and its predictors among children aged 6-59 months admitted with severe acute malnutrition to inpatient therapeutic feeding centers at public hospitals in west Shoa Zone, Western Ethiopia.2022 G.C Annals of medicine and surgery (2012) 87(2):541-554 2025 [PMID: 40110289]
  90. Wiedemann A, Surénaud M, Hubert M, Lopez Zaragoza JL, Ribeiro A, Rodrigues C, Foucat E, Diombera H, Krief C, Schwartz O, Lelièvre JD, Lévy Y. Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines Journal of immunology (Baltimore, Md. : 1950) 214(2):211-222 2025 [PMID: 40073241]
  91. Anagnostou O, Kalpourtzi N, Karakosta A, Terzidis A, Yfantis A, Margalias A, Tzanetea R, Pallis E, Gavana M, Vantarakis A, Chlouverakis G, Touloumi G. Health Needs and Access to Healthcare Services in Migrant Populations in Greece: Data From the Hprolipsis Study Cureus 17(1):e78196 2025 [PMID: 40027004]
  92. Chavda VP. Vaccines reimagined: The peptide revolution in disease prevention Progress in molecular biology and translational science 212:329-354 2025 [PMID: 40122650]
  93. Wolock CJ, Gilbert PB, Simon N, Carone M. Assessing variable importance in survival analysis using machine learning Biometrika 112(2):asae061 2025 [PMID: 40103753]
  94. Juggernath P, Mopeli K, Masekela R, Dangor Z, Goga A, Gray DM, Verwey C. Bronchiectasis in children in a high HIV and tuberculosis prevalence setting African journal of thoracic and critical care medicine 30(4):e1899 2024 [PMID: 40041419]
  95. Liu J, Wong G, Li H, Yang Y, Cao Y, Li Y, Wu Y, Zhang Z, Jin C, Wang X, Chen Y, Su B, Wang Z, Wang Q, Cao Y, Chen G, Qian Z, Zhao J, Wu G. Biosafety and immunology: An interdisciplinary field for health priority Biosafety and health 6(5):310-318 2024 [PMID: 40078733]
  96. Jiang Q, Wu X, Dong F, Qiao S, Shi Q, Jian C, Chen C, Zhou J, Wang Y, Huang W. Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population Biosafety and health 6(5):279-285 2024 [PMID: 40078732]
  97. Camargo-Assis F, Lopez-Mejia Y, Salim-Mattar A, Salim-Mattar. Migrations in Latin America: the corridor to the American dream is a public health problem Revista de salud publica (Bogota, Colombia) 26(3):114016 2024 [PMID: 40098944]
  98. Fang Y, Wang F, Jiang T, Duan J, Huang T, Liu H, Jia L, Jia H, Yan B, Zhang M, Wang W, Guo C, Liu L, Zhang Y, Zhang T. Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report Biosafety and health 6(3):186-190 2024 [PMID: 40078726]

Marburg virus

  1. Ebenig A, Lange MV, Gellhorn Serra M, Kupke A, Plesker R, Qu B, Brown RJP, Maier TJ, Mühlebach MD. Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19 NPJ vaccines 10(1):51 2025 [PMID: 40097436]
  2. Singh RK, Sarkar K, Das RK. In-silico repurposing of antiviral compounds against Marburg virus: a computational drug discovery approach In silico pharmacology 13(1):41 2025 [PMID: 40061630]
  3. Lee YZ, Zhang YN, Newby ML, Ward G, Gomes KB, Auclair S, DesRoberts C, Allen JD, Ward AB, Stanfield RL, He L, Crispin M, Wilson IA, Zhu J. Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modification bioRxiv : the preprint server for biology 2025 [PMID: 40060701]
  4. Saadh MJ, Muhammad FA, Albadr RJ, Sanghvi G, Jyothi SR, Kundlas M, Joshi KK, Gulyamov S, Taher WM, Alwan M, Jawad MJ, Al-Nuaimi AMA. From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application Archives of microbiology 207(4):74 2025 [PMID: 40025302]
  5. Havens JL, Kosakovsky Pond SL, Zehr JD, Pekar JE, Parker E, Worobey M, Andersen KG, Wertheim JO. Dynamics of natural selection preceding human viral epidemics and pandemics bioRxiv : the preprint server for biology 2025 [PMID: 40060453]

Mycobacterium tuberculosis (tuberculosis)

  1. Guo J, Jia Z, Yang Y, Wang N, Xue Y, Xiao L, Wang F, Wang L, Wang X, Liu Y, Wang J, Gong W, Zhao H, Liang Y, Wu X. Bioinformatics analysis, immunogenicity, and therapeutic efficacy evaluation of a novel multi-stage, multi-epitope DNA vaccine for tuberculosis International immunopharmacology 152:114415 2025 [PMID: 40086060]
  2. Hilligan KL, Darrah PA, Seder RA, Sher A. Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance The Journal of experimental medicine 222(4) 2025 [PMID: 40100096]
  3. Abdalla A, Elbakri AS, Almatrooshi CA, AlNaqeeb NB, Hussain NU, Gaba WH, Fazal F. Unexpected Deltoid Abscess from BCG Vaccination in a Healthy Adult: A Case Report The American journal of case reports 26:e946723 2025 [PMID: 40131858]
  4. Schwartz YS, Semenova OV, Salmin AV. Aminobisphosphonates Potentiate Non-Specific Immunological Memory Bulletin of experimental biology and medicine 2025 [PMID: 40131671]
  5. Boggiatto PM, Sterle H, Fernandes L, Hamby H, VerCauteren K, Feuka A, Campa H 3rd, Kanipe C, Olsen SC, Palmer MV. Oral delivery of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in alginate spheres to captive white-tailed deer BMC veterinary research 21(1):193 2025 [PMID: 40119424]
  6. Putz EJ, Andreasen CB, Stasko JA, Hamond C, Olsen SC, Nally JE, Palmer MV. Circulating foamy macrophages and other features of bacillus Calmette-Guérin challenge in Golden Syrian hamsters Vaccine 55:127037 2025 [PMID: 40117727]
  7. de Souza VA, Caparroz ALMA, Trevisani VFM, Gomes Tavares ACFM, de Melo AKG, Trajman A, Medeiros-Ribeiro AC, Pinheiro MM, Xavier RM, Monticielo OA, Guimarães MFBR, Sztajnbok F, Bombarda S, Chebli LA, Kakehasi AM, Bierrenbach AL, Gomides Reis APM, Gomes Bica BER, Marques CDL, Flores C, Rodrigues DS, Paiva EDS, Matos ED, Costa Johansen FD, Bacha HA, de Carvalho JS, Provenza JR, Lira Machado KLL, da Mota LMH, Valadares LDA, Rocha Loures MAAD, Pretti Dalcolmo MM, Bortoletto MCC, Ferreira Lopes MIB, Abreu Vieira RMR, Romiti R, Saad-Hossne R, Ciconelli RM, Feijó Azevedo V, Augusto VM, Alves Cruz V, Salviato Pileggi GC. Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases Advances in rheumatology (London, England) 65(1):18 2025 [PMID: 40114289]
  8. Minute L, Montalbán-Hernández K, Bravo-Robles L, Conejero L, Iborra S, Del Fresno C. Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections Trends in immunology 2025 [PMID: 40113536]
  9. Adeagbo BA, Alao M, Orherhe O, Akinloye A, Boukes G, Willenburg E, Fenner C, Bolaji OO, Fox CB. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ) Molecular pharmaceutics 2025 [PMID: 40105111]
  10. Jurczak M, Kaczmarek J, Kowalewska-Pietrzak M, Druszczynska M. Immunomodulatory Effect of the Bacillus Calmette-Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens Archivum immunologiae et therapiae experimentalis 73(1) 2025 [PMID: 40101137]
  11. Tameris M, Rozot V, Imbratta C, Geldenhuys H, Mendelsohn SC, Kany Luabeya AK, Shenje J, Tredoux N, Fisher M, Mulenga H, Bilek N, Young C, Veldsman A, Botes N, Thole J, Fritzell B, Mukherjee R, Jelsbak IM, Rodriguez E, Puentes E, Doce J, Marinova D, Gonzalo-Asensio J, Aguilo N, Martin C, Scriba TJ, Hatherill M. Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting EBioMedicine 114:105628 2025 [PMID: 40101388]
  12. Almeida CF, Juno JA. Sensing mycobacteria through unconventional pathways The Journal of clinical investigation 135(6) 2025 [PMID: 40091837]
  13. Barik S, Aldar KS, Chakraborty A, Panda AK, Kar RK, Biswas A. Understanding the structural and functional implications of lysine succinylation in Mycobacterium tuberculosis heat shock protein 16.3 International journal of biological macromolecules 307(Pt 3):142046 2025 [PMID: 40089242]
  14. Navarro CE, Benjumea-Bedoya D, Estupinan-Bohorquez AF, Florez ID. Cost-effectiveness analysis comparing QuantiFERON test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent children under 15 years of age in Colombia BMJ open 15(3):e087333 2025 [PMID: 40081973]
  15. Vincent JP, Ségéral O, Kania D, Borand L, Adoukara JP, Pivert A, Koné A, Tiendrebeogo ASE, Tall H, Schaeffer L, Vray M, Sanou AM, Njouom R, Cloherty G, Hashimoto N, Miura T, Sugiura W, Sovann S, Yang JS, Delvallez G, Lunel-Fabiani F, Tanaka Y, Shimakawa Y. Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study The lancet. Gastroenterology & hepatology 2025 [PMID: 40090346]
  16. N AlGhazi A, H AlZahrani M, AlMutiri WA, AlZoum NM. Disseminated tuberculosis presenting as finger swelling in a 2-year-old: a case report of TB osteomyelitis Case reports in plastic surgery & hand surgery 12(1):2473383 2025 [PMID: 40078577]
  17. Clay PA, Pollock ED, Saldarriaga EM, Pathela P, Macaraig M, Zucker JR, Crouch B, Kracalik I, Spicknall IH. Modeling the Impact of Vaccine Dose Prioritization Strategies During the 2022 Mpox Outbreak American journal of epidemiology 2025 [PMID: 40069944]
  18. Aisenstat M, McCollum J, Ordoubadi M, Wang H, Minootan Z, Gerhardt A, Martin AR, Fox CB, Vehring R. Scale-up of a low-temperature spray-drying process for a tuberculosis vaccine candidate using lab-scale equipment International journal of pharmaceutics 674:125456 2025 [PMID: 40074162]
  19. Kgoadi K, Bajpai P, Ibegbu CC, Dkhar HK, Enriquez AB, Dawa S, Cribbs SK, Rengarajan J. Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection Nature communications 16(1):2397 2025 [PMID: 40064940]
  20. Barik S, Pritam P, Chakraborty A, Das S, Dutta SP, Mohapatra SS, Gupta B, Panda AK, Biswas A. Mycobacterial Small Heat Shock Proteins: Dissecting Their Roles in Pathogenesis and Development of Therapeutics ACS infectious diseases 2025 [PMID: 40063058]
  21. Sossen B, Kubjane M, Meintjes G. Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107876 2025 [PMID: 40064284]
  22. Trajman A, Campbell JR, Kunor T, Ruslami R, Amanullah F, Behr MA, Menzies D. Tuberculosis Lancet (London, England) 405(10481):850-866 2025 [PMID: 40057344]
  23. Arce-Estrada GE, Rodríguez-Morales M, Scheffler-Mendoza SC, Sáez-de-Ocariz M, Berrón-Ruiz L, Espinosa-Padilla SE, Contreras-Verduzco FA. Case Report: A novel IKBKB variant (c.1705G>T) is associated with immune dysregulation and disseminated tuberculosis Frontiers in immunology 16:1541899 2025 [PMID: 40124362]
  24. Ou X, Liu E, Rashid F, Pei S, Zhang G, Anthony R, Xing R, Huang F, Xia H, Zheng Y, Song Y, Zhou Y, Zhao B, Wang S, Lin M, Zhou L, Zhao Y. Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing Frontiers in immunology 16:1498448 2025 [PMID: 40124357]
  25. Skalland TM, de Dieu Tapsoba J, Zangeneh SZ, Floyd S, Ayles H, Bock P, Fidler S, Eshleman SH, Hayes RJ, Donnell D. A survey weighted analysis of HPTN 071 (PopART) primary outcome of HIV incidence AIDS research and therapy 22(1):30 2025 [PMID: 40055795]
  26. Cao X, Gao L, Xin H, Zhu L, Duan W, Feng B, Lu W, Liu Z, He Y, Shen L, Huang J, Zhang B, Wang D, Yan J, Chen C, Wang L, Yin W, Wang G, Guo T, Di Y, Li Z, Liang J, Zhao Y, Li H, Shen F, Du J, Jin Q. The dynamic change of tuberculosis infection prevalence in rural residents: 10-year follow-up of a population-based, multicentre cohort study from China The Lancet regional health. Western Pacific 56:101509 2025 [PMID: 40125311]
  27. Dill-McFarland KA, Peterson G, Lim PN, Skerrett S, Hawn TR, Rothchild AC, Campo M. Shared and distinct responses of human and murine alveolar macrophages and monocyte-derived macrophages to Mycobacterium tuberculosis bioRxiv : the preprint server for biology 2025 [PMID: 40093075]
  28. Gong W, Du J. Evaluating H56:IC31 vaccine in tuberculosis recurrence prevention The Lancet. Infectious diseases 2025 [PMID: 40056923]
  29. Borges ÁH, Russell M, Tait D, Scriba TJ, Nemes E, Skallerup P, van Brakel E, Cabibbe AM, Cirillo DM, Leuvennink-Steyn M, Rutkowski KT, Wood GK, Thierry-Carstensen B, Tingskov PN, Meldgaard EC, Kristiansen MP, Søndergaard RE, Hansen CH, Follmann F, Jensen CG, Gela A, Ntinginya NE, Ruhwald M, Shenje J, White L, Innes C, Selepe P, Ngaraguza B, Holmgren C, Collings T, Andersen P, Dawson R, Churchyard G, Sabi I, Diacon AH, Mortensen R, Hatherill M. Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial The Lancet. Infectious diseases 2025 [PMID: 40056922]
  30. Sitenda D, Ssekamatte P, Nakavuma R, Kyazze AP, Bongomin F, Baluku JB, Nabatanzi R, Kibirige D, Wilkinson RJ, Nakimuli A, Cose S, Andia-Biraro I. Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda BMC immunology 26(1):13 2025 [PMID: 40038578]
  31. Mehta A, Pant A. Post coronavirus-disease-vaccination immune reconstitution inflammatory syndrome in tuberculosis treatment: a case report Journal of medical case reports 19(1):93 2025 [PMID: 40033413]
  32. Liu L, Zhao J, Wang Y, Chen X, Zhang S, Li M, You L, Liu Y. Equity of National Essential Public Health Services (NEPHS) in Mainland China, 2019: a cross-sectional study based on the NEPHS database Globalization and health 21(1):6 2025 [PMID: 40033352]
  33. Tengattini S, Bavaro T, Rinaldi F, Temporini C, Pollegioni L, Terreni M, Piubelli L. Novel tuberculosis vaccines based on TB10.4 and Ag85B: State-of-art and advocacy for good practices Vaccine 53:126932 2025 [PMID: 40031085]
  34. Hati B, Biswas D, Bhattacharjee S, Dey A. A Clinicoradiological and Bacteriological Profile of Community-acquired Pneumonia in a Tertiary Care Center in Eastern India The Journal of the Association of Physicians of India 73(3):25-29 2025 [PMID: 40087928]
  35. Wu Q, Zhu Y, Zhang Y, Liu Z, Zhang M, Chen J, Wu B. Evaluation and Comparison of Laboratory Methods in Diagnosing Mycobacterium tuberculosis and Nontuberculous Mycobacteria in 3012 Sputum Samples The clinical respiratory journal 19(3):e70071 2025 [PMID: 40087831]
  36. Campana F, Noel G, Rajabizadeh M, Harimanana A, Rafetrarivony L, Delvallez G, Hide M, Meng S, Razafimahatratra SL, Dim B, Ait-Ahmed M, Borand L, Collard JM, Guiso N, Taieb F. Seroprevalence of Diphtheria in Antananarivo, Madagascar, and Cambodia Open forum infectious diseases 12(3):ofaf091 2025 [PMID: 40066087]
  37. Miller M, Gómez MA, Tanner R, Vermaak S, Villarreal-Ramos B. Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasis Vaccine 53:126929 2025 [PMID: 40023904]
  38. Ocan M, Katusiime M, Kyabayinze D, Kwesiga B, Ayebare R, Nakasendwa S, Mbabazi L, Bosa HK, Nansiiro H, Sanger D, Tayebwa M, Tusiime B, Kiragga A, Kakooza F, Gonese E, Shaweno T, Dereje N, Fallah MP, Ario AR. COVID-19 vaccine uptake and associated factors among health workers in Kampala city, Uganda Journal of public health in Africa 16(1):720 2025 [PMID: 40083474]
  39. Guo M, Ling X, He L, Gou Y, Li Z, Li W. NapR Regulates the Expression of Phosphoserine Aminotransferase SerC to Modulate Biofilm Formation and Resistance to Serine Stress of Mycobacteria International journal of molecular sciences 26(5) 2025 [PMID: 40076802]
  40. Stetsenko V, Gail DP, Reba S, Suzart VG, Sandhu AK, Sette A, Dezfulian MH, Arlehamn CSL, Carpenter SM. Human memory CD4(+) T-cells recognize Mycobacterium tuberculosis-infected macrophages amid broader pathogen-specific responses bioRxiv : the preprint server for biology 2025 [PMID: 40060660]
  41. Tientcheu L, Faal F, Top N, Jobe O, Colley SM, Ayorinde A, Mendy A, Sarr-Kuyateh B, Donkor S, Antonio M, de Jong B, Rachow A, Kampmann B, Sutherland JS, Li H, Blundell T, Campino S, Kohl T, Dreyer V, Niemann S, Pandurangan A, Clark T, Phelan J. Genome-wide analyses of Mycobacterium tuberculosis complex isolates reveal insights into circulating lineages and drug resistance mutations in The Gambia Research square 2025 [PMID: 40060042]
  42. McCaffrey EF, Delmastro AC, Fitzhugh I, Ranek JS, Douglas S, Peters JM, Fullaway CC, Bosse M, Liu CC, Gillen C, Greenwald NF, Anzick S, Martens C, Winfree S, Bai Y, Sowers C, Goldston M, Kong A, Boonrat P, Bigbee CL, Venugopalan R, Maiello P, Klein E, Rodgers MA, Scanga CA, Lin PL, Kirschner D, Fortune S, Bryson BD, Butler JR, Mattila JT, Flynn JL, Angelo M. The immunometabolic topography of tuberculosis granulomas governs cellular organization and bacterial control bioRxiv : the preprint server for biology 2025 [PMID: 40027668]
  43. Alfaleh R, Alsuwailem WA, Almazyad RT, Alanazi FF, Alanazi LT. The Impact of Armed Conflicts on the Prevalence, Transmission, and Management of Infectious Diseases: A Systematic Review Cureus 17(2):e79450 2025 [PMID: 40130145]
  44. Divens AM, Ma L, Vance JK, Povroznik JM, Hu G, Robinson CM. IL-27 producers in a neonatal BCG vaccination model are a heterogenous population of myeloid cells that are diverse in phenotype and function ImmunoHorizons 9(4) 2025 [PMID: 40048708]
  45. Jamaati H, Karimi S, Arshi S, Zahraei SM, Panahi Y, Nouri F, Hajimoradi M, Hasanzade A, Mokhtari M, Tayeri K, Abedini A, Mohamadnia A, Tabarsi P, Sharif-Kashani B, Marjani M, Rashid Farokhi F, Hashemian SMR, Hosseini-Baharanchi FS, Norizadeh M, Astani B, Noorali S, Ahmadi F, Shafaghi S, Ghorbani F. Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis Frontiers in immunology 16:1504973 2025 [PMID: 40028315]
  46. Takemoto K, Kounami S, Shimoe T, Fukui D, Tokuhara D. Bacillus Calmette Guérin Osteomyelitis of the Proximal Tibia Extending to the Physis and Epiphysis in an Immunocompetent Toddler: A Case Report Cureus 17(2):e78385 2025 [PMID: 40041632]
  47. Ravikoti S, Bhatia V, Mohanasundari SK. Recent advancements in tuberculosis (TB) treatment regimens Journal of family medicine and primary care 14(2):521-525 2025 [PMID: 40115547]
  48. Mekonnen C, Abebe M, Mosisa W. A retrospective cohort studying about time to recovery and its predictors among children aged 6-59 months admitted with severe acute malnutrition to inpatient therapeutic feeding centers at public hospitals in west Shoa Zone, Western Ethiopia.2022 G.C Annals of medicine and surgery (2012) 87(2):541-554 2025 [PMID: 40110289]
  49. Juggernath P, Mopeli K, Masekela R, Dangor Z, Goga A, Gray DM, Verwey C. Bronchiectasis in children in a high HIV and tuberculosis prevalence setting African journal of thoracic and critical care medicine 30(4):e1899 2024 [PMID: 40041419]
  50. Camargo-Assis F, Lopez-Mejia Y, Salim-Mattar A, Salim-Mattar. Migrations in Latin America: the corridor to the American dream is a public health problem Revista de salud publica (Bogota, Colombia) 26(3):114016 2024 [PMID: 40098944]
  51. Fang Y, Wang F, Jiang T, Duan J, Huang T, Liu H, Jia L, Jia H, Yan B, Zhang M, Wang W, Guo C, Liu L, Zhang Y, Zhang T. Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report Biosafety and health 6(3):186-190 2024 [PMID: 40078726]

Nipah virus

  1. Kim S, Kang H, Skrip L, Sahastrabuddhe S, Islam A, Jung SM, Vesga JF, Endo A, Edmunds WJ, Abbas K. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response Expert review of vaccines 24(1):183-193 2025 [PMID: 40047506]
  2. Ruedas-Torres I, Findlay-Wilson S, Kennedy E, Dowall S, Salguero FJ. Pathology and host-pathogen interactions in a golden Syrian hamster model of Nipah virus infection Frontiers in veterinary science 12:1518358 2025 [PMID: 40125323]
  3. Findlay-Wilson S, Thakur N, Crossley L, Easterbrook L, Salguero FJ, Ruedas-Torres I, Fotheringham S, Kennedy E, Bailey D, Dowall S. Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease Frontiers in immunology 16:1517244 2025 [PMID: 40078997]

Plasmodium falciparum (Malaria)

  1. Saif A, Baruah P, Wazid SW, Panigrahi A, Han JH, Ahmed MA, Quan FS. In silico comparative analysis of genetic diversity and natural selection of Plasmodium knowlesi and Plasmodium vivax etramp11.2 gene Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 129:105733 2025 [PMID: 40023377]
  2. Mwesigwa A, Tukwasibwe S, Cummings B, Kawalya H, Kiyaga S, Okoboi S, Castelnuovo B, Bikaitwoha EM, Kalyango JN, Nsobya SL, Karamagi C, Byakika-Kibwika P, Nankabirwa JI. Genetic diversity and population structure of Plasmodium falciparum across areas of varied malaria transmission intensities in Uganda Malaria journal 24(1):97 2025 [PMID: 40128854]
  3. Thomson RM, Cunningham JA, Gatton MM, Murphy SC, de la Paz Ade M, Ding XC, Incardona S, Legrand E, Lucchi N, Menard D, Nsobya SL, Saez AC, Shrivastava J, Chiodini PL. WHO malaria nucleic acid amplification test external quality assessment scheme: results of eleven distributions over 6 years Malaria journal 24(1):94 2025 [PMID: 40122815]
  4. Fumwakwau JK, Schedwin M, Ngale MA, Hildenwall H, Alfven T, Mapatano MA, King C, Phanzu DM. Mortality in children and adolescents in Western Democratic Republic of Congo: retrospective analysis of verbal autopsy and demographic data from the Kimpese Health and Demographic Surveillance System BMJ paediatrics open 9(1) 2025 [PMID: 40121016]
  5. Gotoh K, Kakimoto K. Transition of Yellow Fever Immunization Environment in Japan Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy :102685 2025 [PMID: 40122518]
  6. Kheirkhah O, Pirahmadi S, Mehrizi AA, Raz A. Population genetic structure of the fibrinogen-related protein 1 (FREP1) in Iranian isolates of Anopheles stephensi as a promising mosquito-based malaria vaccine candidate Gene :149436 2025 [PMID: 40122414]
  7. Nguyen NN, Duong L, Doan MB, Nguyen HD. Surface display of LukF-PV on Bacillus subtilis spore for oral administration Future microbiology :1-9 2025 [PMID: 40116634]
  8. Bogacka A, Wroczyńska A, Grzybek M. Polish travellers on the move: a study of knowledge of travel health and associated practices among Polish travellers abroad Travel medicine and infectious disease :102842 2025 [PMID: 40120919]
  9. Ntihebuwayo E, Nimpagaritse M, Bizimana T, Banzimana S, Kabura D, Sinarinzi P, Asingizwe D. Acceptance of a malaria vaccine among caregivers of sick children under 5 years of age in Burundi Malaria journal 24(1):90 2025 [PMID: 40114138]
  10. Saleem Z, Mekonnen BA, Orubu ES, Islam MA, Nguyen TTP, Ubaka CM, Buma D, Thuy NDT, Sant Y, Sono TM, Bochenek T, Kalungia AC, Abdullah S, Miljković N, Yeika E, Niba LL, Akafity G, Sefah IA, Opanga SA, Kitutu FE, Khuluza F, Zaranyika T, Parajuli A, Darweesh O, Islam S, Kumar S, Nabayiga H, Jairoun AA, Chigome A, Ogunleye O, Fadare J, Massele A, Cook A, Jelić AG, Godói IPD, Phillip A, Meyer JC, Funiciello E, Lorenzetti G, Kurdi A, Haseeb A, Moore CE, Campbell SM, Godman B, Sharland M. Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications Expert review of anti-infective therapy 2025 [PMID: 40110804]
  11. Agbenyega T, Schuind AE, Adjei S, Antony K, Aponte JJ, Buabeng PBY, Clemens JD, Hossain L, Kemp TJ, Mercer LD, Pinto LA, Qadri F, Sukraw K, Bhat N, Zaman K. Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial The Lancet. Infectious diseases 2025 [PMID: 40120597]
  12. Yun SY, Nguyen MN, Hong H, Bae GJ, Eom TH, Hoang VT, Park H, Yeo SJ. Immunogenicity and efficacy in mice of two adjuvant formulations based on the C -and N-terminus of merozoite surface protein 1 of Plasmodium yoelii Vaccine 55:127032 2025 [PMID: 40112557]
  13. Adeyemi O, Osuntoki A, Magbagbeola O, Abdel Hamid MM, Elaagip A, Mueller AK, Ibrahim M. Evidence for infectious merozoites of Plasmodium falciparum from natural isolates of cultured hepatoma cells infected with sporozoites PloS one 20(3):e0319901 2025 [PMID: 40106488]
  14. Rodriguez-Morales AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Millán-Oñate J, Lopardo G, Arce OA, Cimerman S, Chaves TDSS, Orduna T, Lloveras S, Cabrera M, Thormann M, Özsürekçi Y, Pérez-Sánchez C, Sandoval N, Zambrano L, Alvarez-Moreno CA, Chacon-Cruz E, Villamil-Gomez WE, Arteaga-Livias K, Savio-Larriera E, Cardona-Ospina JA, Risquez A, Forero-Peña DA, Contreras K, Sah R, León-Figueroa DA, Acosta-España JD, Sierra L, López-Delgado DS, Solarte-Portilla MA, Escobedo AA, Haque S, Amer FA, Leblebicioglu H, Ulloa-Gutierrez R, Galan-Rodas E, Matsee W, Fernandez ML, Echazarreta S, Cabieses B, Espinal C, Brea J, Navarro JC, Lezcano VG, Otero-Maldonado M, Echevarría-Cofiño R, Diaz B, Quispe-Torrez PP, Angerami RN, Avila-Aguero ML, Debbag R, Guevara ME, Carrero Y, Torres-Martinez CN, Membrillo FJ, Suarez JA. Infectious Diseases Prevention and Vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien Gap, Panama Travel medicine and infectious disease :102839 2025 [PMID: 40113189]
  15. Souffou M, Dechavanne C, Kammoun Z, Viwami F, Gaugué I, Beldjoudi N, Dechavanne S, Sare N, Garcia A, Dambrun M, Migot-Nabias F. Functionality of Toxoplasma gondii antibodies in a population of Beninese pregnant women exposed to malaria Scientific reports 15(1):9303 2025 [PMID: 40102442]
  16. Balam S, Miura K, Ayadi I, Konaté D, Incandela NC, Agnolon V, Guindo MA, Diakité SAS, Olugbile S, Nebie I, Herrera SM, Long C, Kajava AV, Diakité M, Corradin G, Herrera S, Herrera MA. Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa PloS one 20(3):e0302605 2025 [PMID: 40100850]
  17. Palaniraman R. Approach to Short Duration Fever in Children in Office Practice Indian journal of pediatrics 2025 [PMID: 40100610]
  18. Song Y, Huang WC, Ivanochko D, Long C, Li Q, Zhou L, Julien JP, Miura K, Lovell JF. 50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen ACS nano 19(10):10103-10112 2025 [PMID: 40099532]
  19. Patel PN, Diouf A, Dickey TH, Tang WK, Hopp CS, Traore B, Long CA, Miura K, Crompton PD, Tolia NH. A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade Cell reports. Medicine 6(3):101985 2025 [PMID: 40020675]
  20. Parveen S, Rath PP, Tabrez S, Khan S, Singh P, Arkam SZ, Verma S, Ahmad S, Singh SK, Junaid IT, Kumar D, Theisen M, Gupta D, Mohmmed A, Salunke DM, Singh AP, Malhotra P. Novel, fully human, anti-PfCSP antibodies with potent antimalarial activity using a phage display based strategy Vaccine 54:126993 2025 [PMID: 40101454]
  21. Berry AA, Richie TL, Church LWP, Laurens MB, Boyce C, Kc N, Joshi S, Koudjra AR, Butler L, Chen MC, Abebe Y, Murshedkar T, James ER, Billingsley PF, Sim BKL, Hoffman SL, Lyke KE. Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection Malaria journal 24(1):88 2025 [PMID: 40098097]
  22. Han JW, Shin EC. Investigating Human Liver Tissue-Resident Memory T Cells from the Perspectives of Gastroenterologists and Hepatologists Gut and liver 19(2):161-170 2025 [PMID: 40058791]
  23. Dass S, Kundu P, Naskar D, Kanjee U, Ferreira MU, Rayner JC, Duraisingh MT. Miniaturized assay to evaluate Plasmodium cynomolgi and P. knowlesi as models for prioritizing P. vivax vaccine targets The Journal of infectious diseases 2025 [PMID: 40083318]
  24. Kimario AD, Gibore NS, Ngowi AF, Masika GM. Antenatal care services utilization and their associated factors among postnatal women in Dodoma city: a cross-sectional study BMC pregnancy and childbirth 25(1):276 2025 [PMID: 40082813]
  25. Murray HW. Vaccines for International Travelers: Current Status and Recent Developments The American journal of medicine 2025 [PMID: 40086773]
  26. Frooman MB, Choi K, Kahn MZ, Yang LY, Cunningham A, RisCassi JM, McShan AC. Identification and biophysical characterization of Plasmodium peptide binding by common African HLAs Scientific reports 15(1):8614 2025 [PMID: 40074802]
  27. Dwivedi A, Scalsky RJ, Harris DG, Stabler TC, Shrestha B, Joshi S, Gandhi C, Munro JB, Ifeonu OO, Ouedraogo A, Tiono AB, Coulibaly D, Ouattara A, Richie TL, Sim BKL, Plowe CV, Lyke KE, Takala-Harrison S, Hoffman SL, Thera MA, Sirima SB, Laurens MB, Silva JC. Protective targets of PfSPZ vaccines identified from whole-genome sieve analysis of isolates from malaria vaccine efficacy trials in West Africa medRxiv : the preprint server for health sciences 2025 [PMID: 40093207]
  28. Aremu DO, Maxim A, Aremu SO, Aremu DE, Terhemen YD, Itodo SO, Barkhadle AA. The interplay of socio-demographic factors and disease prevalence: insights into malaria, Hepatitis B, and Hepatitis C in Lafia, Nasarawa State, Nigeria Journal of health, population, and nutrition 44(1):67 2025 [PMID: 40051006]
  29. Akowe E, Ahman QO, Agbata BC, Joseph SO, Senewo EO, Danjuma AY, Yahaya DJ. A novel malaria mathematical model: integrating vector and non-vector transmission pathways BMC infectious diseases 25(1):322 2025 [PMID: 40050782]
  30. Dong Y, Kang S, Sandiford SL, Pike A, Simões ML, Ubalee R, Kobylinski K, Dimopoulos G. Targeting the mosquito prefoldin-chaperonin complex blocks Plasmodium transmission Nature microbiology 2025 [PMID: 40050397]
  31. van Schuijlenburg R, Naar CM, van der Wees S, Chevalley-Maurel SC, Duszenko N, de Bes-Roeleveld HM, Iliopoulou E, Houlder EL, Geurten FJA, Baalbergen E, Roestenberg M, Franke-Fayard B. Early Activation of Lung CD8(+) T Cells After Immunization with Live Plasmodium berghei Malaria Sporozoites Pathogens & immunity 10(2):46-68 2025 [PMID: 40062354]
  32. Yovogan B, Djènontin A, Akogbéto MC, Sovi A, Adoha CJ, Fassinou A, Salako AS, Odjo EM, Assongba L, Accrombessi M, Dangbénon E, Assogba BS, Ahogni I, Missihoun AA, Akpodji S, Agossa F, Azondékon R, Koukpo CZ, Padonou GG, Ngufor C, Cook J, Protopopoff N, Messenger LA, Agbangla C. Impact of dual active ingredients long-lasting insecticidal nets on the genetic structure of insecticide resistant populations of Anopheles gambiae in Southern Benin Malaria journal 24(1):72 2025 [PMID: 40033284]
  33. Deshmukh B, Khatri D, Kochar SK, Athale C, Karmodiya K. In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum Vaccine 53:126952 2025 [PMID: 40037124]
  34. Adeleke MA. Computational Development of Transmission-Blocking Vaccine Candidates Based on Fused Antigens of Pre- and Post-fertilization Gametocytes Against Plasmodium falciparum Bioinformatics and biology insights 19:11779322241306215 2025 [PMID: 40034580]
  35. Mafuta EM, Lulebo AM, Kasonga JN, Mvuama NM, Luhata CL, Hoff NA, Nkamba DM, Merritt S, Otomba JS, Mbunga BK, Cikomola AMWB, Rimoin AW, Mukendi JC, LeGargasson JB, Nogier C, Kinuani L, Nimpa MM, Ishoso DK, Mudipanu AN, Manirakiza D, Kaba DK, Nyandwe JK, Danovaro-Holliday MC, El Mourid A, Lusamba PD. Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018-2023 Vaccine 53:126956 2025 [PMID: 40031089]
  36. Nampota-Nkomba N, Nyirenda OM, Datta S, Mapemba V, Patel PD, Misiri T, Mwakiseghile F, Ndaferankhande JM, Lipenga B, Oshinsky J, Pasetti MF, Jamka LP, Gordon MA, Laurens MB, Neuzil KM. Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children EClinicalMedicine 81:103100 2025 [PMID: 40034570]
  37. Munyakanage D, Niyituma E, Mutabazi A, Misago X, Musanabaganwa C, Remera E, Rutayisire E, Ingabire MM, Mbituyumuremyi A, Ngugi MP, Kokwaro E, Asingizwe D, Hakizimana E, Muvunyi CM. Factors affecting community participation in drone-based larviciding using Bacillus thuringiensis var. israelensis (Bti) for bio-control of malaria vectors in Rwanda Malaria journal 24(1):67 2025 [PMID: 40025519]
  38. Onyamboko M, Wasakul V, Bakomba SB, Kayembe DK, Nzambiwishe BK, Ekombolo PE, Badjanga BB, Maindombe JM, Ngavuka JN, Lwadi BN, Drury E, Ariani C, Goncalves S, Chamsukhee V, Waithira N, Verschuuren TD, Lee SJ, Miotto O, Fanello C. Pregnant women as a sentinel population for genomic surveillance of malaria in the Democratic Republic of the Congo: a population-based study The Lancet. Global health 13(3):e479-e487 2025 [PMID: 40021306]
  39. Tembo T, Heilmann E, Kabamba BM, Fwoloshi S, Kalenga K, Chilambe F, Siwinga M, Rutagwera MR, Musunse M, Kangale C, Yingst S, Yadav R, Savory T, Gutman JR, Sikazwe I, Mulenga LB, Moore CB, Hines JZ. Implementing SARS-CoV-2 routine surveillance in antenatal care in Zambia, 2021-2022: best practices and lessons learned BMC public health 25(1):813 2025 [PMID: 40021963]
  40. Presser A, Blaser G, Pferschy-Wenzig EM, Kaiser M, Mäser P, Schuehly W. Pharmacomodulation of the Redox-Active Lead Plasmodione: Synthesis of Substituted 2-Benzylnaphthoquinone Derivatives, Antiplasmodial Activities, and Physicochemical Properties International journal of molecular sciences 26(5) 2025 [PMID: 40076744]
  41. Yuguchi T, Dankyi BO, Rojrung R, Nagaoka H, Kanoi BN, Tiono AB, Nebie I, Ouedraogo A, Miura K, Sattabongkot J, Sirima SB, Tsuboi T, Takashima E. Antibody responses in Burkinabe children against P. falciparum proteins associated with reduced risk of clinical malaria Frontiers in immunology 16:1521082 2025 [PMID: 40079008]
  42. Muyidi AA, Ayashi MA, Wakid MH, Alghanmi MS, Baakdah FM, Gattan HS, Alsaady IM, Alsulami MN, Albohiri HH, Altwaim SA, Eisa ZM, Brek TM. Evaluation of Two Multiplexed qPCR Assays for Malaria Detection and Speciation: A Comparative Study With Nested PCR and Microscopy Journal of parasitology research 2025:4950793 2025 [PMID: 40041801]
  43. Mazhar I, Rai MM, Ahmad A, Nadeem N, Javed AS, Mumtaz H. Recent Vaccines against Emerging and Tropical Infectious Diseases Discoveries (Craiova, Romania) 12(2):e187 2024 [PMID: 40093847]
  44. Camargo-Assis F, Lopez-Mejia Y, Salim-Mattar A, Salim-Mattar. Migrations in Latin America: the corridor to the American dream is a public health problem Revista de salud publica (Bogota, Colombia) 26(3):114016 2024 [PMID: 40098944]

Rickettsia prowazekii (Typhus fever)

  1. Felice AG, Rodrigues TCV, Marques PH, Zen FL, Lemes MR, Trevisan RO, Andrade BS, de Oliveira CJF, Azevedo VAC, Tiwari S, Soares SC. In silico construction of a multi-epitope vaccine (RGME-VAC/ATS-1) against the Rickettsia genus using immunoinformatics Memorias do Instituto Oswaldo Cruz 120:e240201 2025 [PMID: 40136144]
  2. Devamani C, Alexander N, Chandramohan D, Stenos J, Cameron M, Abhilash KPP, Mangtani P, Blacksell S, Vu HTT, Rose W, Schmidt WP. Incidence of Scrub Typhus in Rural South India The New England journal of medicine 392(11):1089-1099 2025 [PMID: 40073309]

Salmonella

  1. Vashishtha VM, Kumar P. Typhoid conjugate vaccines: is a single dose enough for durable protection? Expert review of vaccines 24(1):194-205 2025 [PMID: 40047496]
  2. Song L, Cui Y, Wang Q, Tan R, Wen Y, Meng C, Jiao X, Pan Z. Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine Viral immunology 2025 [PMID: 40127244]
  3. Bakin BC, Stolte-Carroll K, Sigman J, Ritchie SM, Tillman GE, Bilanovic I, Kowalcyk BB. A Systematic Review on Preharvest Interventions Used to Control Salmonella in Poultry Rearing in the United States Journal of food protection 88(4):100474 2025 [PMID: 40023401]
  4. Liao Y-S, Hong Y-P, Chen B-H, Wang Y-W, Teng R-H, Chien Y-C, Liang S-Y, Wei HL, Chang J-H, Yang M-H, Tsao C-S, Chiou C-S. Clonal expansion of chromosome-borne CTX-M-55 extended-spectrum β-lactamase-producing Salmonella enterica serovar Agona, Taiwan Microbiology spectrum :e0297924 2025 [PMID: 40102208]
  5. McTernan SP, Heller J, Clulow JR, Gannon L, Huang R, Tidd N, Blishen A, Hughes KJ. The prevalence, serotypes and antibiograms of Salmonella isolates on Thoroughbred stud farms in New South Wales and Victoria Australian veterinary journal 2025 [PMID: 40084645]
  6. Ali S, Mehboob A, Arshad M, Mammadova K, Ahmad MU. Bacterial oncolytic therapy as a novel approach for cancer treatment in humans Cancer treatment and research communications 43:100892 2025 [PMID: 40088595]
  7. Kahraman T, Yagci FC, Ceylan A, Calik A, Tarman IO, Kiran F. A novel trivalent inactivated Salmonella vaccine formulated with CpG ODNs to enhance the cellular immunity in chickens Poultry science 104(5):105024 2025 [PMID: 40120243]
  8. Pietruska A, Macklin KS, Wang X, Krehling JT, Dormitorio T, Hauck R. Investigation of Intestinal Health in Broiler Chickens Following Salmonella Typhimurium and Coccidiosis Vaccination and Challenge with Salmonella Typhimurium The journal of poultry science 62:2025009 2025 [PMID: 40060328]
  9. Thøfner I, Olsen M, Poulsen LL. Lack of reproducibility compromises conclusions on the effects of three Bacillus species on Salmonella enterica Enteritidis colonisation in layer-type chickens British poultry science :1-6 2025 [PMID: 40052811]
  10. Adeleke MA. Computational Development of Transmission-Blocking Vaccine Candidates Based on Fused Antigens of Pre- and Post-fertilization Gametocytes Against Plasmodium falciparum Bioinformatics and biology insights 19:11779322241306215 2025 [PMID: 40034580]
  11. Ahmad AAM, Hussien EAM, Elian AAAM, Abdelmoneim M, Ali A, Abdelhamid AE, Elmowalid GA. Nigella sativa monophosphoryl lipid A nanoliposome: a promising antibiotic alternative and immunomodulator to control virulent pandemic drug-resistant Salmonella pullorum infection in broiler chicks BMC veterinary research 21(1):132 2025 [PMID: 40025471]
  12. Khosravi V, Mahdavi AH, Hatamzade Esfahani N. Effects of Zataria multiflora, Salvia officinalis and Probiotics on Intestinal Microbial Colonization, Immunocompetence, Jejunal Histology and Performance of Laying Hens Veterinary medicine and science 11(2):e70147 2025 [PMID: 40132055]
  13. Nampota-Nkomba N, Nyirenda OM, Datta S, Mapemba V, Patel PD, Misiri T, Mwakiseghile F, Ndaferankhande JM, Lipenga B, Oshinsky J, Pasetti MF, Jamka LP, Gordon MA, Laurens MB, Neuzil KM. Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children EClinicalMedicine 81:103100 2025 [PMID: 40034570]
  14. An SJ, Yang JS, Chae MH, Woo JS, Kang YE, Ganapathy R, Pansuriya RK, Choi JA, Yoon YK, Lee E, Lee SB, Pandey G, Lee JW, Lee JS, Bae SH, Kweon SW, Kim SJ, Seon SH, Kim JH, Song M. Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine Vaccine 52:126913 2025 [PMID: 40020336]
  15. Piryaei MR, Peighambari SM, Razmyar J. Drug resistance and genotyping studies of Salmonella Enteritidis isolated from broiler chickens in Iran Frontiers in veterinary science 12:1542313 2025 [PMID: 40041666]
  16. Goel K, Verma M, Sharma N, Parida SP, Bhardwaj A, Nadda A, Sharma S, Sen A, John J, Bansal A, Gupta M. IAPSM's Position Paper on Typhoid Vaccines for Adult Immunization in India Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 49(Suppl 2):S139-S145 2024 [PMID: 40124874]

Shigella

  1. Halder S, Jaiswal N, Balajee SC, Mahata N. Efficient production of a novel recombinant fusion protein of EIEC effector IpaD and EGFP: Biophysical characterization and functional studies Biochimica et biophysica acta. Proteins and proteomics 1873(4):141066 2025 [PMID: 40086498]

Variola major (Smallpox)

  1. Tripathi P, Pandey S, Yadav D, Joshi S. Emergence and evolution of monkeypox virus: Epidemiology, pathology, clinical symptoms, preventative and treatment measures International immunopharmacology 152:114448 2025 [PMID: 40073815]
  2. Deng Y, Navarro-Forero S, Yang Z. Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes mBio :e0380924 2025 [PMID: 40111027]
  3. Hillus D, Le NH, Tober-Lau P, Fietz AK, Hoffmann C, Stegherr R, Huang L, Baumgarten A, Voit F, Bickel M, Goldstein G, Wyen C, Stocker H, Wünsche T, Lee M, Schulbin H, Vallée M, Bohr U, Potthoff A, Cordes C, Isner C, Knox B, Carmona A, Stobäus N, Balicer R, Kurth F, Sander LE. Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study The Lancet. Infectious diseases 2025 [PMID: 40118087]
  4. Belay DB, Ali MI, Chen DG, Jama UA. Prevalence and associated factors of immunization among under-five children in Somalia BMC public health 25(1):924 2025 [PMID: 40057683]
  5. Jadhav V, Paul A, Trivedi V, Bhatnagar R, Bhalsinge R, Jadhav SV. Global epidemiology, viral evolution, and public health responses: a systematic review on Mpox (1958-2024) Journal of global health 15:04061 2025 [PMID: 40048320]
  6. Okita G, Suenaga K, Sakaguchi M, Murakami T. A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells PloS one 20(3):e0312205 2025 [PMID: 40048445]
  7. Hershan AA. Virology, epidemiology, transmissions, diagnostic tests, prophylaxis and treatments of human Mpox: Saudi Arabia perspective Frontiers in cellular and infection microbiology 15:1530900 2025 [PMID: 40093536]
  8. Nikitin VN, Merkuleva IA, Shcherbakov DN. Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models Antibodies (Basel, Switzerland) 14(1) 2025 [PMID: 40136469]
  9. Wiedemann A, Surénaud M, Hubert M, Lopez Zaragoza JL, Ribeiro A, Rodrigues C, Foucat E, Diombera H, Krief C, Schwartz O, Lelièvre JD, Lévy Y. Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines Journal of immunology (Baltimore, Md. : 1950) 214(2):211-222 2025 [PMID: 40073241]
  10. Wu C, Zhang Z, Li Z, Li R, Huo S, Li H, Lu R, Tian H, Wang W, Zhao L, Huang B, Deng Y, Tan W. Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression Biosafety and health 6(5):286-297 2024 [PMID: 40078737]
  11. Fang Y, Wang F, Jiang T, Duan J, Huang T, Liu H, Jia L, Jia H, Yan B, Zhang M, Wang W, Guo C, Liu L, Zhang Y, Zhang T. Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report Biosafety and health 6(3):186-190 2024 [PMID: 40078726]

Vibrio cholerae

  1. Izzoddeen A, Abualgasim H, Abasher M, Elnoor H, Magbol M, Fadlelmoula S, Abolgassim A, Dafaalla AH, Elgamry K, Banaga A, Magboul B, M Osman M, Mahmoud E. Cholera in conflict: outbreak analysis and response lessons from Gadaref state, Sudan (2023-2024) BMC public health 25(1):881 2025 [PMID: 40045292]
  2. Davis KL, Nieznanski C, Maisha F, Brintz BJ, Clutter C, Alam M, Saleem C, Ali A, Morris JG, Leung DT. Kinetics of vibriocidal antibody responses among cholera patients in Goma, the Democratic Republic of Congo medRxiv : the preprint server for health sciences 2025 [PMID: 40061355]

Yersinia pestis (Plague)

  1. Luo S, Yin L, Liu X, Wang X. Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases Biosensors 15(3) 2025 [PMID: 40136995]
  2. Parums DV. Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials Medical science monitor : international medical journal of experimental and clinical research 31:e948672 2025 [PMID: 40022523]
  3. Diaz M, Mikulski Z, Leaman D, Gandarilla A, Da Silva N, Verkoczy A, Zhang J, Verkoczy L. SARS-CoV-2 spike peptide analysis reveals a highly conserved region that elicits potentially pathogenic autoantibodies: implications to pan-coronavirus vaccine development Frontiers in immunology 16:1488388 2025 [PMID: 40070822]

Click HERE to see the publications in the last month.